activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650540	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1650540	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4954	Homo sapiens	Kd		
	1650541	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	4100.0	CHEMBL4954	Homo sapiens	Kd	uM	4.1
Not Active	1650542	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1650543	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1650544	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1650545	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4954	Homo sapiens	Kd		
	1650546	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	6400.0	CHEMBL4954	Homo sapiens	Kd	uM	6.4
Not Active	1650547	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1650548	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4954	Homo sapiens	Kd		
	1651346	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	55.0	CHEMBL4954	Homo sapiens	Kd	uM	0.055
Not Active	1651347	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1651348	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1651349	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4954	Homo sapiens	Kd		
	1651350	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	580.0	CHEMBL4954	Homo sapiens	Kd	uM	0.58
	1651351	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	4000.0	CHEMBL4954	Homo sapiens	Kd	uM	4.0
Not Active	1651352	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1651353	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4954	Homo sapiens	Kd		
Not Active	1651354	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4954	Homo sapiens	Kd		
	1651355	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1800.0	CHEMBL4954	Homo sapiens	Kd	uM	1.8
	1651356	CHEMBL860778	Average Binding Constant for EPHA3; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	650.0	CHEMBL4954	Homo sapiens	Kd	uM	0.65
	2081785	CHEMBL928808	Inhibition of EphA3 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL4954	Homo sapiens	Inhibition	%	20.0
	2147248	CHEMBL922823	Activity of human EphA3 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	88.0	CHEMBL4954	Homo sapiens	Activity	%	88.0
Not Active	2170356	CHEMBL930311	Activity at Hek at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL4954	Homo sapiens	Activity		
	2206892	CHEMBL973089	Inhibition of EphA3 by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	2.0	CHEMBL4954	Homo sapiens	EC50	nM	2.0
	2206940	CHEMBL973089	Inhibition of EphA3 by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL4954	Homo sapiens	EC50	uM	1.0
	2395445	CHEMBL961272	Binding affinity to EPHA3 at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL4954	Homo sapiens	Activity	%	10.0
	2395473	CHEMBL963601	Inhibition of Epha3 by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL4954	Homo sapiens	IC50	nM	500.0
	2470170	CHEMBL1034119	Inhibition of EPHA3 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4954	Homo sapiens	INH	%	10.0
	2476655	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	8.9	CHEMBL4954	Homo sapiens	Activity	%	8.9
Not Evaluated	2476858	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2478697	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4954	Homo sapiens	Activity		
	2479538	CHEMBL988932	Binding affinity to human EPHA3	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	0.1	CHEMBL4954	Homo sapiens	Kd	nM	0.1
	2479572	CHEMBL988932	Binding affinity to human EPHA3	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Kd	nM	46.0	CHEMBL4954	Homo sapiens	Kd	nM	46.0
Not Evaluated	2479755	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2480552	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4954	Homo sapiens	Activity		
Active	2480754	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4954	Homo sapiens	Activity		
	2511575	CHEMBL972534	Inhibition of EPHA3	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	48.0	CHEMBL4954	Homo sapiens	IC50	uM	0.048
	2527198	CHEMBL984179	Inhibition of HEK	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523	=	IC50	nM	3200.0	CHEMBL4954	Homo sapiens	IC50	uM	3.2
Not Evaluated	2577376	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4954	Homo sapiens	Activity		
	2593581	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	4.7	CHEMBL4954	Homo sapiens	Activity	%	4.7
Active	2593784	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2593847	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2594050	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2594993	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4954	Homo sapiens	Activity		
Active	2595262	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4954	Homo sapiens	Activity		
Not Evaluated	2596190	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4954	Homo sapiens	Activity		
	2596393	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	11.5	CHEMBL4954	Homo sapiens	Activity	%	11.5
	2597662	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	0.6	CHEMBL4954	Homo sapiens	Activity	%	0.6
Not Evaluated	2597865	CHEMBL1024907	Binding affinity to human EPHA3 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4954	Homo sapiens	Activity		
	2719562	CHEMBL1059974	Inhibition of Tel fused EphA3 expressed in mouse BA/F3 cells	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140	<	EC50	nM	500.0	CHEMBL4954	Homo sapiens	EC50	nM	500.0
	2721020	CHEMBL1061755	Inhibition of EphA3 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	2904859	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	3500.0	CHEMBL4954	Homo sapiens	Kd	nM	3500.0
	2904860	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904861	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	80.0	CHEMBL4954	Homo sapiens	Kd	nM	80.0
	2904862	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904863	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	880.0	CHEMBL4954	Homo sapiens	Kd	nM	880.0
	2904864	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904865	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904866	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904867	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	2904868	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904869	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904870	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.093	CHEMBL4954	Homo sapiens	Kd	nM	0.093
	2904871	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	4000.0	CHEMBL4954	Homo sapiens	Kd	nM	4000.0
	2904872	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2400.0	CHEMBL4954	Homo sapiens	Kd	nM	2400.0
	2904873	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3300.0	CHEMBL4954	Homo sapiens	Kd	nM	3300.0
	2904874	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904875	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904876	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904877	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904878	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904879	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904880	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904881	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904882	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	2904883	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904884	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904885	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904886	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904887	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904888	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904889	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904890	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL4954	Homo sapiens	Kd	nM	1900.0
	2904891	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	27.0	CHEMBL4954	Homo sapiens	Kd	nM	27.0
	2904892	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904893	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	2904894	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1500.0	CHEMBL4954	Homo sapiens	Kd	nM	1500.0
	2904895	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	2904896	CHEMBL1061145	Binding constant for EPHA3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2000.0	CHEMBL4954	Homo sapiens	Kd	nM	2000.0
	2921358	CHEMBL1056100	Inhibition of EPHA3 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	74.0	CHEMBL4954	Homo sapiens	Activity	%	74.0
	2926274	CHEMBL1046772	Inhibition of EphA3 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	40.0	CHEMBL4954	Homo sapiens	IC50	nM	40.0
	3006323	CHEMBL1038371	Inhibition of Hek	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL4954	Homo sapiens	IC50	uM	7.0
	3006324	CHEMBL1038371	Inhibition of Hek	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	=	IC50	nM	9000.0	CHEMBL4954	Homo sapiens	IC50	uM	9.0
	3006325	CHEMBL1038371	Inhibition of Hek	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	=	IC50	nM	8000.0	CHEMBL4954	Homo sapiens	IC50	uM	8.0
	3006326	CHEMBL1038371	Inhibition of Hek	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	=	IC50	nM	7000.0	CHEMBL4954	Homo sapiens	IC50	uM	7.0
	3052593	CHEMBL1037134	Residual activity of EPHA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL4954	Homo sapiens	Residual activity	%	96.0
	3053902	CHEMBL1044302	Residual activity of EPHA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	143.0	CHEMBL4954	Homo sapiens	Residual activity	%	143.0
	3054154	CHEMBL1050282	Residual activity of EPHA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	92.0	CHEMBL4954	Homo sapiens	Residual activity	%	92.0
	3055441	CHEMBL1037134	Residual activity of EPHA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL4954	Homo sapiens	Residual activity	%	96.0
	3055693	CHEMBL1044302	Residual activity of EPHA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	236.0	CHEMBL4954	Homo sapiens	Residual activity	%	236.0
	3056998	CHEMBL1050282	Residual activity of EPHA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL4954	Homo sapiens	Residual activity	%	104.0
	3058318	CHEMBL1037134	Residual activity of EPHA3 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	90.0	CHEMBL4954	Homo sapiens	Residual activity	%	90.0
	3058570	CHEMBL1044302	Residual activity of EPHA3 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	182.0	CHEMBL4954	Homo sapiens	Residual activity	%	182.0
	3072916	CHEMBL1050282	Residual activity of EPHA3 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	106.0	CHEMBL4954	Homo sapiens	Residual activity	%	106.0
	3213799	CHEMBL1108386	Inhibition of EPHA3 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	100.0	CHEMBL4954	Homo sapiens	INH	%	100.0
	3224807	CHEMBL1102801	Inhibition of EPHA3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3225057	CHEMBL1102801	Inhibition of EPHA3 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3331917	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3333332	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3334737	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3336157	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3337512	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3337761	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3339095	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3340397	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3340685	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3342101	CHEMBL1169207	Inhibition of EPHA3 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	3358552	CHEMBL1174397	Inhibition of EPHA3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.85	CHEMBL4954	Homo sapiens	INH	%	0.85
	3358994	CHEMBL1174397	Inhibition of EPHA3 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.75	CHEMBL4954	Homo sapiens	INH	%	0.75
	3443384	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	68.0	CHEMBL4954	Homo sapiens	INH	%	68.0
	3443601	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	55.0	CHEMBL4954	Homo sapiens	INH	%	55.0
	3444756	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	29.0	CHEMBL4954	Homo sapiens	INH	%	29.0
	3445103	CHEMBL1244814	Binding affinity to EPHA3	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	160.0	CHEMBL4954	Homo sapiens	Kd	nM	160.0
	3445380	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	34.0	CHEMBL4954	Homo sapiens	INH	%	34.0
	3445597	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	18.0	CHEMBL4954	Homo sapiens	INH	%	18.0
	3445806	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	80.0	CHEMBL4954	Homo sapiens	INH	%	80.0
	3445996	CHEMBL1244417	Inhibition of EPHA3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	25.0	CHEMBL4954	Homo sapiens	INH	%	25.0
	3448411	CHEMBL1244814	Binding affinity to EPHA3	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	3448736	CHEMBL1244814	Binding affinity to EPHA3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	3449419	CHEMBL1244814	Binding affinity to EPHA3	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL4954	Homo sapiens	Kd	nM	1900.0
	3449420	CHEMBL1244814	Binding affinity to EPHA3	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	3449647	CHEMBL1244814	Binding affinity to EPHA3	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	3450979	CHEMBL1244814	Binding affinity to EPHA3	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	uM	10.0
	3463217	CHEMBL1252305	Inhibition of EPHA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-5.0	CHEMBL4954	Homo sapiens	INH	%	-5.0
	3463436	CHEMBL1252305	Inhibition of EPHA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	14.0	CHEMBL4954	Homo sapiens	INH	%	14.0
	3463980	CHEMBL1252305	Inhibition of EPHA3 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	13.0	CHEMBL4954	Homo sapiens	INH	%	13.0
	5120269	CHEMBL1645949	Inhibition of human EphA3 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	90.0	CHEMBL4954	Homo sapiens	INH	%	90.0
	5243693	CHEMBL1685656	Inhibition of EphA3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	81.0	CHEMBL4954	Homo sapiens	INH	%	81.0
	5243801	CHEMBL1685905	Inhibition of EphA3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	14.0	CHEMBL4954	Homo sapiens	INH	%	14.0
	5243914	CHEMBL1685656	Inhibition of EphA3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	89.0	CHEMBL4954	Homo sapiens	INH	%	89.0
	5244022	CHEMBL1685905	Inhibition of EphA3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	29.0	CHEMBL4954	Homo sapiens	INH	%	29.0
	5244895	CHEMBL1685656	Inhibition of EphA3 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	109.0	CHEMBL4954	Homo sapiens	INH	%	109.0
	5245003	CHEMBL1685905	Inhibition of EphA3 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	93.0	CHEMBL4954	Homo sapiens	INH	%	93.0
	5245154	CHEMBL1685656	Inhibition of EphA3 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	134.0	CHEMBL4954	Homo sapiens	INH	%	134.0
	5245984	CHEMBL1685905	Inhibition of EphA3 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	109.0	CHEMBL4954	Homo sapiens	INH	%	109.0
	6219890	CHEMBL1785578	Inhibition of human EPHA3 using poly[Glu:Tyr] peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	1.2	CHEMBL4954	Homo sapiens	IC50	nM	1.2
	6265540	CHEMBL1799803	Inhibition of EPHA3 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4954	Homo sapiens	INH	%	65.0
	6265644	CHEMBL1799803	Inhibition of EPHA3 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL4954	Homo sapiens	INH	%	65.0
	6341047	CHEMBL1828216	Activity of EPHA3 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	7567407	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	3700.0	CHEMBL4954	Homo sapiens	Kd	nM	3700.0
	7567895	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7568363	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	7.6	CHEMBL4954	Homo sapiens	Kd	nM	7.6
	7568795	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2300.0	CHEMBL4954	Homo sapiens	Kd	nM	2300.0
	7569380	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7569398	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7569870	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7570333	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7570760	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	7571371	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	700.0	CHEMBL4954	Homo sapiens	Kd	nM	700.0
	7571847	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	6100.0	CHEMBL4954	Homo sapiens	Kd	nM	6100.0
	7572310	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7572726	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	4000.0	CHEMBL4954	Homo sapiens	Kd	nM	4000.0
	7572895	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7573352	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.093	CHEMBL4954	Homo sapiens	Kd	nM	0.093
	7573828	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1600.0	CHEMBL4954	Homo sapiens	Kd	nM	1600.0
	7574297	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7574705	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7574873	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	8600.0	CHEMBL4954	Homo sapiens	Kd	nM	8600.0
	7575334	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2400.0	CHEMBL4954	Homo sapiens	Kd	nM	2400.0
	7575805	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7576270	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7576678	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	7100.0	CHEMBL4954	Homo sapiens	Kd	nM	7100.0
	7576847	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7577306	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1.0	CHEMBL4954	Homo sapiens	Kd	nM	1.0
	7577784	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	810.0	CHEMBL4954	Homo sapiens	Kd	nM	810.0
	7578855	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7579229	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	880.0	CHEMBL4954	Homo sapiens	Kd	nM	880.0
	7579679	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3300.0	CHEMBL4954	Homo sapiens	Kd	nM	3300.0
	7580180	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	390.0	CHEMBL4954	Homo sapiens	Kd	nM	390.0
	7580583	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2000.0	CHEMBL4954	Homo sapiens	Kd	nM	2000.0
	7581213	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	2500.0	CHEMBL4954	Homo sapiens	Kd	nM	2500.0
	7581598	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7582043	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7582072	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7582536	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7582936	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1500.0	CHEMBL4954	Homo sapiens	Kd	nM	1500.0
	7583559	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	3500.0	CHEMBL4954	Homo sapiens	Kd	nM	3500.0
	7583956	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7584430	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7584892	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	360.0	CHEMBL4954	Homo sapiens	Kd	nM	360.0
	7585296	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7586301	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7586772	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7587226	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7587408	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	6500.0	CHEMBL4954	Homo sapiens	Kd	nM	6500.0
	7587827	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7588280	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	5500.0	CHEMBL4954	Homo sapiens	Kd	nM	5500.0
	7588751	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7589202	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7589373	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7589797	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	160.0	CHEMBL4954	Homo sapiens	Kd	nM	160.0
	7590264	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7590738	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7591189	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7591346	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7591768	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7592240	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7592713	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	7593313	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	80.0	CHEMBL4954	Homo sapiens	Kd	nM	80.0
	7593748	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7594220	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7594703	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	5.8	CHEMBL4954	Homo sapiens	Kd	nM	5.8
	7595281	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7595725	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2100.0	CHEMBL4954	Homo sapiens	Kd	nM	2100.0
	7596199	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7596228	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	110.0	CHEMBL4954	Homo sapiens	Kd	nM	110.0
	7596675	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1900.0	CHEMBL4954	Homo sapiens	Kd	nM	1900.0
	7597253	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7597706	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7598207	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	7598649	CHEMBL1908706	Binding constant for EPHA3 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	27.0	CHEMBL4954	Homo sapiens	Kd	nM	27.0
	7959739	CHEMBL1932844	Inhibition of EPHA3	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4954	Homo sapiens	IC50	uM	30.0
	7959740	CHEMBL1932844	Inhibition of EPHA3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	1200.0	CHEMBL4954	Homo sapiens	IC50	uM	1.2
	8047104	CHEMBL1958845	Inhibition of EPHA3 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	8061369	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.13	CHEMBL4954	Homo sapiens	Inhibition	%	3.13
	8061546	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.27	CHEMBL4954	Homo sapiens	Inhibition	%	3.27
	8061653	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.78	CHEMBL4954	Homo sapiens	Inhibition	%	1.78
	8061877	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.18	CHEMBL4954	Homo sapiens	Inhibition	%	4.18
	8062068	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.31	CHEMBL4954	Homo sapiens	Inhibition	%	2.31
	8062408	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.89	CHEMBL4954	Homo sapiens	Inhibition	%	6.89
	8062570	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.23	CHEMBL4954	Homo sapiens	Inhibition	%	-1.23
	8062892	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.12	CHEMBL4954	Homo sapiens	Inhibition	%	-0.12
	8063248	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.67	CHEMBL4954	Homo sapiens	Inhibition	%	2.67
	8063415	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.2	CHEMBL4954	Homo sapiens	Inhibition	%	3.2
	8063747	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.83	CHEMBL4954	Homo sapiens	Inhibition	%	3.83
	8063929	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.83	CHEMBL4954	Homo sapiens	Inhibition	%	4.83
	8064268	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.47	CHEMBL4954	Homo sapiens	Inhibition	%	4.47
	8064478	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.64	CHEMBL4954	Homo sapiens	Inhibition	%	5.64
	8064840	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.2	CHEMBL4954	Homo sapiens	Inhibition	%	-1.2
	8065006	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.4	CHEMBL4954	Homo sapiens	Inhibition	%	3.4
	8065346	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.89	CHEMBL4954	Homo sapiens	Inhibition	%	1.89
	8065521	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.54	CHEMBL4954	Homo sapiens	Inhibition	%	2.54
	8065745	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.44	CHEMBL4954	Homo sapiens	Inhibition	%	3.44
	8065860	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.26	CHEMBL4954	Homo sapiens	Inhibition	%	2.26
	8066070	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.99	CHEMBL4954	Homo sapiens	Inhibition	%	1.99
	8066294	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.26	CHEMBL4954	Homo sapiens	Inhibition	%	-0.26
	8066430	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.63	CHEMBL4954	Homo sapiens	Inhibition	%	1.63
	8066596	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.4	CHEMBL4954	Homo sapiens	Inhibition	%	2.4
	8066820	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.41	CHEMBL4954	Homo sapiens	Inhibition	%	3.41
	8066944	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	13.01	CHEMBL4954	Homo sapiens	Inhibition	%	13.01
	8067343	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.46	CHEMBL4954	Homo sapiens	Inhibition	%	3.46
	8067464	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.01	CHEMBL4954	Homo sapiens	Inhibition	%	4.01
	8067898	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.46	CHEMBL4954	Homo sapiens	Inhibition	%	1.46
	8068033	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.17	CHEMBL4954	Homo sapiens	Inhibition	%	3.17
	8068421	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.39	CHEMBL4954	Homo sapiens	Inhibition	%	2.39
	8068546	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	12.36	CHEMBL4954	Homo sapiens	Inhibition	%	12.36
	8068770	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.47	CHEMBL4954	Homo sapiens	Inhibition	%	1.47
	8068944	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.35	CHEMBL4954	Homo sapiens	Inhibition	%	4.35
	8069069	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.94	CHEMBL4954	Homo sapiens	Inhibition	%	3.94
	8069293	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.1	CHEMBL4954	Homo sapiens	Inhibition	%	5.1
	8069364	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	11.11	CHEMBL4954	Homo sapiens	Inhibition	%	11.11
	8069588	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.03	CHEMBL4954	Homo sapiens	Inhibition	%	2.03
	8069749	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.84	CHEMBL4954	Homo sapiens	Inhibition	%	1.84
	8070099	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.8	CHEMBL4954	Homo sapiens	Inhibition	%	2.8
	8070271	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.89	CHEMBL4954	Homo sapiens	Inhibition	%	3.89
	8070620	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.58	CHEMBL4954	Homo sapiens	Inhibition	%	2.58
	8070918	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.24	CHEMBL4954	Homo sapiens	Inhibition	%	6.24
	8071075	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.32	CHEMBL4954	Homo sapiens	Inhibition	%	3.32
	8071425	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.6	CHEMBL4954	Homo sapiens	Inhibition	%	0.6
	8071598	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.2	CHEMBL4954	Homo sapiens	Inhibition	%	5.2
	8071822	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.55	CHEMBL4954	Homo sapiens	Inhibition	%	6.55
	8071947	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.79	CHEMBL4954	Homo sapiens	Inhibition	%	5.79
	8072261	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.48	CHEMBL4954	Homo sapiens	Inhibition	%	0.48
	8072418	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.87	CHEMBL4954	Homo sapiens	Inhibition	%	2.87
	8072642	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.93	CHEMBL4954	Homo sapiens	Inhibition	%	4.93
	8072767	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.6	CHEMBL4954	Homo sapiens	Inhibition	%	3.6
	8073158	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.24	CHEMBL4954	Homo sapiens	Inhibition	%	4.24
	8073283	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	51.32	CHEMBL4954	Homo sapiens	Inhibition	%	51.32
	8073626	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.01	CHEMBL4954	Homo sapiens	Inhibition	%	-0.01
	8073859	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.56	CHEMBL4954	Homo sapiens	Inhibition	%	2.56
	8074235	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.33	CHEMBL4954	Homo sapiens	Inhibition	%	1.33
	8074365	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.89	CHEMBL4954	Homo sapiens	Inhibition	%	2.89
	8074746	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.08	CHEMBL4954	Homo sapiens	Inhibition	%	2.08
	8074873	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	68.43	CHEMBL4954	Homo sapiens	Inhibition	%	68.43
	8075097	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.15	CHEMBL4954	Homo sapiens	Inhibition	%	0.15
	8075208	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.43	CHEMBL4954	Homo sapiens	Inhibition	%	2.43
	8075445	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.69	CHEMBL4954	Homo sapiens	Inhibition	%	-2.69
	8075810	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.42	CHEMBL4954	Homo sapiens	Inhibition	%	5.42
	8075952	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.92	CHEMBL4954	Homo sapiens	Inhibition	%	1.92
	8076176	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.39	CHEMBL4954	Homo sapiens	Inhibition	%	0.39
	8076324	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.17	CHEMBL4954	Homo sapiens	Inhibition	%	3.17
	8076682	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.49	CHEMBL4954	Homo sapiens	Inhibition	%	3.49
	8076784	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.04	CHEMBL4954	Homo sapiens	Inhibition	%	1.04
	8077008	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.84	CHEMBL4954	Homo sapiens	Inhibition	%	0.84
	8077031	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.11	CHEMBL4954	Homo sapiens	Inhibition	%	1.11
	8077255	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.47	CHEMBL4954	Homo sapiens	Inhibition	%	-1.47
	8077383	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.05	CHEMBL4954	Homo sapiens	Inhibition	%	4.05
	8077758	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.63	CHEMBL4954	Homo sapiens	Inhibition	%	2.63
	8077901	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.06	CHEMBL4954	Homo sapiens	Inhibition	%	3.06
	8078264	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-4.5	CHEMBL4954	Homo sapiens	Inhibition	%	-4.5
	8078590	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.3	CHEMBL4954	Homo sapiens	Inhibition	%	0.3
	8078840	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.7	CHEMBL4954	Homo sapiens	Inhibition	%	-0.7
	8078956	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.6	CHEMBL4954	Homo sapiens	Inhibition	%	4.6
	8079180	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.95	CHEMBL4954	Homo sapiens	Inhibition	%	2.95
	8079338	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.37	CHEMBL4954	Homo sapiens	Inhibition	%	-2.37
	8079480	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.07	CHEMBL4954	Homo sapiens	Inhibition	%	4.07
	8079704	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.64	CHEMBL4954	Homo sapiens	Inhibition	%	4.64
	8079843	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.8	CHEMBL4954	Homo sapiens	Inhibition	%	-0.8
	8080172	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-2.2	CHEMBL4954	Homo sapiens	Inhibition	%	-2.2
	8080424	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.74	CHEMBL4954	Homo sapiens	Inhibition	%	-2.74
	8080763	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.45	CHEMBL4954	Homo sapiens	Inhibition	%	2.45
	8080927	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.69	CHEMBL4954	Homo sapiens	Inhibition	%	1.69
	8081286	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.32	CHEMBL4954	Homo sapiens	Inhibition	%	4.32
	8081430	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.91	CHEMBL4954	Homo sapiens	Inhibition	%	3.91
	8081757	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.53	CHEMBL4954	Homo sapiens	Inhibition	%	0.53
	8082009	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.31	CHEMBL4954	Homo sapiens	Inhibition	%	0.31
	8082346	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	3.28	CHEMBL4954	Homo sapiens	Inhibition	%	3.28
	8082519	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-5.79	CHEMBL4954	Homo sapiens	Inhibition	%	-5.79
	8082866	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.96	CHEMBL4954	Homo sapiens	Inhibition	%	2.96
	8083022	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.22	CHEMBL4954	Homo sapiens	Inhibition	%	4.22
	8083246	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.95	CHEMBL4954	Homo sapiens	Inhibition	%	1.95
	8083345	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-2.04	CHEMBL4954	Homo sapiens	Inhibition	%	-2.04
	8083599	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-7.25	CHEMBL4954	Homo sapiens	Inhibition	%	-7.25
	8083823	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.98	CHEMBL4954	Homo sapiens	Inhibition	%	-1.98
	8083933	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.8	CHEMBL4954	Homo sapiens	Inhibition	%	1.8
	8084118	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.63	CHEMBL4954	Homo sapiens	Inhibition	%	-3.63
	8084342	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	5.42	CHEMBL4954	Homo sapiens	Inhibition	%	5.42
	8084460	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.24	CHEMBL4954	Homo sapiens	Inhibition	%	4.24
	8084845	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.65	CHEMBL4954	Homo sapiens	Inhibition	%	4.65
	8084943	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.66	CHEMBL4954	Homo sapiens	Inhibition	%	1.66
	8085167	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.02	CHEMBL4954	Homo sapiens	Inhibition	%	-1.02
	8085423	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.93	CHEMBL4954	Homo sapiens	Inhibition	%	-4.93
	8085531	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.95	CHEMBL4954	Homo sapiens	Inhibition	%	2.95
	8085944	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.38	CHEMBL4954	Homo sapiens	Inhibition	%	12.38
	8086059	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.01	CHEMBL4954	Homo sapiens	Inhibition	%	3.01
	8086283	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.25	CHEMBL4954	Homo sapiens	Inhibition	%	3.25
	8086445	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.96	CHEMBL4954	Homo sapiens	Inhibition	%	-0.96
	8086768	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.73	CHEMBL4954	Homo sapiens	Inhibition	%	0.73
	8086979	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-0.5	CHEMBL4954	Homo sapiens	Inhibition	%	-0.5
	8087137	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.8	CHEMBL4954	Homo sapiens	Inhibition	%	4.8
	8087361	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.95	CHEMBL4954	Homo sapiens	Inhibition	%	1.95
	8087475	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	12.2	CHEMBL4954	Homo sapiens	Inhibition	%	12.2
	8087837	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.47	CHEMBL4954	Homo sapiens	Inhibition	%	2.47
	8087979	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.57	CHEMBL4954	Homo sapiens	Inhibition	%	3.57
	8088203	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.79	CHEMBL4954	Homo sapiens	Inhibition	%	2.79
	8088351	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.48	CHEMBL4954	Homo sapiens	Inhibition	%	0.48
	8088703	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.7	CHEMBL4954	Homo sapiens	Inhibition	%	1.7
	8088796	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.44	CHEMBL4954	Homo sapiens	Inhibition	%	5.44
	8089020	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.08	CHEMBL4954	Homo sapiens	Inhibition	%	3.08
	8089148	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.71	CHEMBL4954	Homo sapiens	Inhibition	%	-0.71
	8089520	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.78	CHEMBL4954	Homo sapiens	Inhibition	%	2.78
	8089640	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.05	CHEMBL4954	Homo sapiens	Inhibition	%	5.05
	8090044	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.28	CHEMBL4954	Homo sapiens	Inhibition	%	-0.28
	8090209	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.47	CHEMBL4954	Homo sapiens	Inhibition	%	1.47
	8090600	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.7	CHEMBL4954	Homo sapiens	Inhibition	%	3.7
	8090739	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.76	CHEMBL4954	Homo sapiens	Inhibition	%	5.76
	8091168	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.21	CHEMBL4954	Homo sapiens	Inhibition	%	5.21
	8091305	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.3	CHEMBL4954	Homo sapiens	Inhibition	%	5.3
	8091684	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.02	CHEMBL4954	Homo sapiens	Inhibition	%	4.02
	8091800	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.8	CHEMBL4954	Homo sapiens	Inhibition	%	2.8
	8092024	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.86	CHEMBL4954	Homo sapiens	Inhibition	%	4.86
	8092161	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.44	CHEMBL4954	Homo sapiens	Inhibition	%	-1.44
	8092536	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.87	CHEMBL4954	Homo sapiens	Inhibition	%	1.87
	8092684	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.2	CHEMBL4954	Homo sapiens	Inhibition	%	-0.2
	8093037	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.21	CHEMBL4954	Homo sapiens	Inhibition	%	6.21
	8093349	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.86	CHEMBL4954	Homo sapiens	Inhibition	%	2.86
	8093489	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.51	CHEMBL4954	Homo sapiens	Inhibition	%	2.51
	8093852	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.12	CHEMBL4954	Homo sapiens	Inhibition	%	3.12
	8093972	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.46	CHEMBL4954	Homo sapiens	Inhibition	%	5.46
	8094196	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.36	CHEMBL4954	Homo sapiens	Inhibition	%	4.36
	8094376	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.31	CHEMBL4954	Homo sapiens	Inhibition	%	-0.31
	8094551	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.43	CHEMBL4954	Homo sapiens	Inhibition	%	0.43
	8094775	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.78	CHEMBL4954	Homo sapiens	Inhibition	%	1.78
	8094931	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.01	CHEMBL4954	Homo sapiens	Inhibition	%	4.01
	8095071	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	5.58	CHEMBL4954	Homo sapiens	Inhibition	%	5.58
	8095295	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	18.28	CHEMBL4954	Homo sapiens	Inhibition	%	18.28
	8095498	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.62	CHEMBL4954	Homo sapiens	Inhibition	%	5.62
	8095639	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.53	CHEMBL4954	Homo sapiens	Inhibition	%	3.53
	8095863	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.81	CHEMBL4954	Homo sapiens	Inhibition	%	2.81
	8096011	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.64	CHEMBL4954	Homo sapiens	Inhibition	%	1.64
	8096352	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.83	CHEMBL4954	Homo sapiens	Inhibition	%	5.83
	8096491	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.53	CHEMBL4954	Homo sapiens	Inhibition	%	-1.53
	8096715	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.64	CHEMBL4954	Homo sapiens	Inhibition	%	-1.64
	8096871	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.18	CHEMBL4954	Homo sapiens	Inhibition	%	2.18
	8097018	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-3.5	CHEMBL4954	Homo sapiens	Inhibition	%	-3.5
	8097242	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.54	CHEMBL4954	Homo sapiens	Inhibition	%	-1.54
	8097329	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.39	CHEMBL4954	Homo sapiens	Inhibition	%	1.39
	8097549	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.67	CHEMBL4954	Homo sapiens	Inhibition	%	3.67
	8097699	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.62	CHEMBL4954	Homo sapiens	Inhibition	%	-1.62
	8097923	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	7.71	CHEMBL4954	Homo sapiens	Inhibition	%	7.71
	8098056	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.34	CHEMBL4954	Homo sapiens	Inhibition	%	-2.34
	8098400	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.67	CHEMBL4954	Homo sapiens	Inhibition	%	2.67
	8098580	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.86	CHEMBL4954	Homo sapiens	Inhibition	%	0.86
	8098989	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.28	CHEMBL4954	Homo sapiens	Inhibition	%	1.28
	8099133	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	7.79	CHEMBL4954	Homo sapiens	Inhibition	%	7.79
	8099499	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.78	CHEMBL4954	Homo sapiens	Inhibition	%	1.78
	8099693	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.29	CHEMBL4954	Homo sapiens	Inhibition	%	1.29
	8100064	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.28	CHEMBL4954	Homo sapiens	Inhibition	%	3.28
	8100210	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.12	CHEMBL4954	Homo sapiens	Inhibition	%	2.12
	8100550	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.31	CHEMBL4954	Homo sapiens	Inhibition	%	4.31
	8100914	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.69	CHEMBL4954	Homo sapiens	Inhibition	%	-1.69
	8101074	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.75	CHEMBL4954	Homo sapiens	Inhibition	%	2.75
	8101440	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-6.76	CHEMBL4954	Homo sapiens	Inhibition	%	-6.76
	8101625	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.12	CHEMBL4954	Homo sapiens	Inhibition	%	-1.12
	8101878	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.44	CHEMBL4954	Homo sapiens	Inhibition	%	3.44
	8102257	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	40.16	CHEMBL4954	Homo sapiens	Inhibition	%	40.16
	8102388	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.49	CHEMBL4954	Homo sapiens	Inhibition	%	-2.49
	8102732	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.49	CHEMBL4954	Homo sapiens	Inhibition	%	-0.49
	8102910	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.08	CHEMBL4954	Homo sapiens	Inhibition	%	-0.08
	8103134	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.71	CHEMBL4954	Homo sapiens	Inhibition	%	0.71
	8103330	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.11	CHEMBL4954	Homo sapiens	Inhibition	%	2.11
	8103468	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.01	CHEMBL4954	Homo sapiens	Inhibition	%	5.01
	8103692	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.42	CHEMBL4954	Homo sapiens	Inhibition	%	0.42
	8103842	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.66	CHEMBL4954	Homo sapiens	Inhibition	%	4.66
	8104027	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.31	CHEMBL4954	Homo sapiens	Inhibition	%	4.31
	8104399	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.46	CHEMBL4954	Homo sapiens	Inhibition	%	3.46
	8104545	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.34	CHEMBL4954	Homo sapiens	Inhibition	%	-2.34
	8104769	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.23	CHEMBL4954	Homo sapiens	Inhibition	%	0.23
	8104883	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.13	CHEMBL4954	Homo sapiens	Inhibition	%	2.13
	8105247	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.51	CHEMBL4954	Homo sapiens	Inhibition	%	-2.51
	8105413	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.65	CHEMBL4954	Homo sapiens	Inhibition	%	4.65
	8105775	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-5.8	CHEMBL4954	Homo sapiens	Inhibition	%	-5.8
	8106055	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.65	CHEMBL4954	Homo sapiens	Inhibition	%	4.65
	8106220	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.01	CHEMBL4954	Homo sapiens	Inhibition	%	6.01
	8106444	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.03	CHEMBL4954	Homo sapiens	Inhibition	%	0.03
	8106600	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	72.94	CHEMBL4954	Homo sapiens	Inhibition	%	72.94
	8106729	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.4	CHEMBL4954	Homo sapiens	Inhibition	%	2.4
	8106953	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.35	CHEMBL4954	Homo sapiens	Inhibition	%	2.35
	8107074	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.1	CHEMBL4954	Homo sapiens	Inhibition	%	0.1
	8107470	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.31	CHEMBL4954	Homo sapiens	Inhibition	%	3.31
	8107671	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.87	CHEMBL4954	Homo sapiens	Inhibition	%	1.87
	8108030	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	7.65	CHEMBL4954	Homo sapiens	Inhibition	%	7.65
	8108188	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.26	CHEMBL4954	Homo sapiens	Inhibition	%	3.26
	8108363	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.1	CHEMBL4954	Homo sapiens	Inhibition	%	4.1
	8108587	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	8.5	CHEMBL4954	Homo sapiens	Inhibition	%	8.5
	8108734	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.99	CHEMBL4954	Homo sapiens	Inhibition	%	3.99
	8109100	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-1.7	CHEMBL4954	Homo sapiens	Inhibition	%	-1.7
	8109214	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.63	CHEMBL4954	Homo sapiens	Inhibition	%	3.63
	8109438	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.54	CHEMBL4954	Homo sapiens	Inhibition	%	1.54
	8109568	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-1.43	CHEMBL4954	Homo sapiens	Inhibition	%	-1.43
	8109739	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.17	CHEMBL4954	Homo sapiens	Inhibition	%	-0.17
	8109963	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.53	CHEMBL4954	Homo sapiens	Inhibition	%	-0.53
	8110095	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.02	CHEMBL4954	Homo sapiens	Inhibition	%	3.02
	8110374	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.23	CHEMBL4954	Homo sapiens	Inhibition	%	3.23
	8110764	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.47	CHEMBL4954	Homo sapiens	Inhibition	%	1.47
	8110922	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.35	CHEMBL4954	Homo sapiens	Inhibition	%	-2.35
	8111269	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	13.88	CHEMBL4954	Homo sapiens	Inhibition	%	13.88
	8111396	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.02	CHEMBL4954	Homo sapiens	Inhibition	%	1.02
	8111620	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.32	CHEMBL4954	Homo sapiens	Inhibition	%	0.32
	8111786	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.36	CHEMBL4954	Homo sapiens	Inhibition	%	1.36
	8111991	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.3	CHEMBL4954	Homo sapiens	Inhibition	%	2.3
	8112352	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.57	CHEMBL4954	Homo sapiens	Inhibition	%	-0.57
	8112520	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.45	CHEMBL4954	Homo sapiens	Inhibition	%	7.45
	8112916	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.44	CHEMBL4954	Homo sapiens	Inhibition	%	0.44
	8113068	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.27	CHEMBL4954	Homo sapiens	Inhibition	%	4.27
	8113428	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.9	CHEMBL4954	Homo sapiens	Inhibition	%	0.9
	8113776	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.0	CHEMBL4954	Homo sapiens	Inhibition	%	3.0
	8113892	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-7.44	CHEMBL4954	Homo sapiens	Inhibition	%	-7.44
	8114292	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.95	CHEMBL4954	Homo sapiens	Inhibition	%	2.95
	8114424	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.57	CHEMBL4954	Homo sapiens	Inhibition	%	8.57
	8114648	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.15	CHEMBL4954	Homo sapiens	Inhibition	%	3.15
	8114700	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.5	CHEMBL4954	Homo sapiens	Inhibition	%	5.5
	8114924	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.14	CHEMBL4954	Homo sapiens	Inhibition	%	5.14
	8115090	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	25.61	CHEMBL4954	Homo sapiens	Inhibition	%	25.61
	8115255	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.0	CHEMBL4954	Homo sapiens	Inhibition	%	-1.0
	8115599	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	10.08	CHEMBL4954	Homo sapiens	Inhibition	%	10.08
	8115956	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.12	CHEMBL4954	Homo sapiens	Inhibition	%	-1.12
	8116115	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.22	CHEMBL4954	Homo sapiens	Inhibition	%	-0.22
	8116318	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.7	CHEMBL4954	Homo sapiens	Inhibition	%	2.7
	8116542	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.03	CHEMBL4954	Homo sapiens	Inhibition	%	1.03
	8116676	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.37	CHEMBL4954	Homo sapiens	Inhibition	%	2.37
	8116848	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	27.42	CHEMBL4954	Homo sapiens	Inhibition	%	27.42
	8117072	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	68.62	CHEMBL4954	Homo sapiens	Inhibition	%	68.62
	8117243	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.32	CHEMBL4954	Homo sapiens	Inhibition	%	2.32
	8117401	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.69	CHEMBL4954	Homo sapiens	Inhibition	%	1.69
	8117625	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.22	CHEMBL4954	Homo sapiens	Inhibition	%	3.22
	8117755	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-2.51	CHEMBL4954	Homo sapiens	Inhibition	%	-2.51
	8118117	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.56	CHEMBL4954	Homo sapiens	Inhibition	%	-1.56
	8118233	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-7.43	CHEMBL4954	Homo sapiens	Inhibition	%	-7.43
	8118457	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.06	CHEMBL4954	Homo sapiens	Inhibition	%	3.06
	8118629	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.34	CHEMBL4954	Homo sapiens	Inhibition	%	2.34
	8118989	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.97	CHEMBL4954	Homo sapiens	Inhibition	%	4.97
	8119260	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.57	CHEMBL4954	Homo sapiens	Inhibition	%	3.57
	8119419	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	43.82	CHEMBL4954	Homo sapiens	Inhibition	%	43.82
	8119586	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.44	CHEMBL4954	Homo sapiens	Inhibition	%	0.44
	8119810	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.58	CHEMBL4954	Homo sapiens	Inhibition	%	0.58
	8119929	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.83	CHEMBL4954	Homo sapiens	Inhibition	%	2.83
	8120292	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.81	CHEMBL4954	Homo sapiens	Inhibition	%	1.81
	8120452	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.81	CHEMBL4954	Homo sapiens	Inhibition	%	1.81
	8120676	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.31	CHEMBL4954	Homo sapiens	Inhibition	%	-0.31
	8120877	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.69	CHEMBL4954	Homo sapiens	Inhibition	%	3.69
	8121005	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.36	CHEMBL4954	Homo sapiens	Inhibition	%	-0.36
	8121401	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.25	CHEMBL4954	Homo sapiens	Inhibition	%	2.25
	8121568	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.59	CHEMBL4954	Homo sapiens	Inhibition	%	0.59
	8121955	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.18	CHEMBL4954	Homo sapiens	Inhibition	%	1.18
	8122076	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.66	CHEMBL4954	Homo sapiens	Inhibition	%	1.66
	8122300	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.52	CHEMBL4954	Homo sapiens	Inhibition	%	-0.52
	8122438	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.81	CHEMBL4954	Homo sapiens	Inhibition	%	0.81
	8122782	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.11	CHEMBL4954	Homo sapiens	Inhibition	%	4.11
	8122949	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.48	CHEMBL4954	Homo sapiens	Inhibition	%	4.48
	8123315	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.35	CHEMBL4954	Homo sapiens	Inhibition	%	-0.35
	8123593	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.85	CHEMBL4954	Homo sapiens	Inhibition	%	1.85
	8123743	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.47	CHEMBL4954	Homo sapiens	Inhibition	%	4.47
	8124134	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.39	CHEMBL4954	Homo sapiens	Inhibition	%	-3.39
	8124253	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.56	CHEMBL4954	Homo sapiens	Inhibition	%	4.56
	8124477	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.37	CHEMBL4954	Homo sapiens	Inhibition	%	4.37
	8124616	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.0	CHEMBL4954	Homo sapiens	Inhibition	%	0.0
	8125005	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.9	CHEMBL4954	Homo sapiens	Inhibition	%	0.9
	8125206	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.68	CHEMBL4954	Homo sapiens	Inhibition	%	4.68
	8125336	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.64	CHEMBL4954	Homo sapiens	Inhibition	%	1.64
	8125560	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.3	CHEMBL4954	Homo sapiens	Inhibition	%	-1.3
	8125728	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.5	CHEMBL4954	Homo sapiens	Inhibition	%	3.5
	8125892	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.71	CHEMBL4954	Homo sapiens	Inhibition	%	0.71
	8126116	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.58	CHEMBL4954	Homo sapiens	Inhibition	%	-0.58
	8126280	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.38	CHEMBL4954	Homo sapiens	Inhibition	%	3.38
	8126619	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	25.17	CHEMBL4954	Homo sapiens	Inhibition	%	25.17
	8126755	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.37	CHEMBL4954	Homo sapiens	Inhibition	%	3.37
	8127101	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.44	CHEMBL4954	Homo sapiens	Inhibition	%	2.44
	8127268	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.01	CHEMBL4954	Homo sapiens	Inhibition	%	6.01
	8127492	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	8.12	CHEMBL4954	Homo sapiens	Inhibition	%	8.12
	8127634	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.13	CHEMBL4954	Homo sapiens	Inhibition	%	7.13
	8127922	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.2	CHEMBL4954	Homo sapiens	Inhibition	%	3.2
	8128074	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	8.46	CHEMBL4954	Homo sapiens	Inhibition	%	8.46
	8128298	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.48	CHEMBL4954	Homo sapiens	Inhibition	%	6.48
	8128465	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.79	CHEMBL4954	Homo sapiens	Inhibition	%	-0.79
	8128808	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	8.81	CHEMBL4954	Homo sapiens	Inhibition	%	8.81
	8128945	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.74	CHEMBL4954	Homo sapiens	Inhibition	%	2.74
	8129340	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.49	CHEMBL4954	Homo sapiens	Inhibition	%	0.49
	8129529	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.67	CHEMBL4954	Homo sapiens	Inhibition	%	4.67
	8129892	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.05	CHEMBL4954	Homo sapiens	Inhibition	%	-0.05
	8130053	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.4	CHEMBL4954	Homo sapiens	Inhibition	%	3.4
	8130449	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.43	CHEMBL4954	Homo sapiens	Inhibition	%	-0.43
	8130609	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-1.76	CHEMBL4954	Homo sapiens	Inhibition	%	-1.76
	8130949	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.49	CHEMBL4954	Homo sapiens	Inhibition	%	2.49
	8131088	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	6.86	CHEMBL4954	Homo sapiens	Inhibition	%	6.86
	8131312	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.31	CHEMBL4954	Homo sapiens	Inhibition	%	4.31
	8131432	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.03	CHEMBL4954	Homo sapiens	Inhibition	%	4.03
	8131823	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	16.96	CHEMBL4954	Homo sapiens	Inhibition	%	16.96
	8131964	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	18.39	CHEMBL4954	Homo sapiens	Inhibition	%	18.39
	8132250	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.56	CHEMBL4954	Homo sapiens	Inhibition	%	1.56
	8132621	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.52	CHEMBL4954	Homo sapiens	Inhibition	%	8.52
	8132789	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.03	CHEMBL4954	Homo sapiens	Inhibition	%	1.03
	8133134	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.21	CHEMBL4954	Homo sapiens	Inhibition	%	2.21
	8133272	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.24	CHEMBL4954	Homo sapiens	Inhibition	%	1.24
	8133496	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.31	CHEMBL4954	Homo sapiens	Inhibition	%	3.31
	8133668	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.83	CHEMBL4954	Homo sapiens	Inhibition	%	-1.83
	8133848	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.72	CHEMBL4954	Homo sapiens	Inhibition	%	0.72
	8134072	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.49	CHEMBL4954	Homo sapiens	Inhibition	%	4.49
	8134220	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-3.56	CHEMBL4954	Homo sapiens	Inhibition	%	-3.56
	8134380	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.73	CHEMBL4954	Homo sapiens	Inhibition	%	4.73
	8134604	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.99	CHEMBL4954	Homo sapiens	Inhibition	%	1.99
	8134788	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-5.95	CHEMBL4954	Homo sapiens	Inhibition	%	-5.95
	8134948	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.69	CHEMBL4954	Homo sapiens	Inhibition	%	0.69
	8135172	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.5	CHEMBL4954	Homo sapiens	Inhibition	%	3.5
	8135287	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.77	CHEMBL4954	Homo sapiens	Inhibition	%	2.77
	8135652	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.04	CHEMBL4954	Homo sapiens	Inhibition	%	5.04
	8135773	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.65	CHEMBL4954	Homo sapiens	Inhibition	%	-2.65
	8135997	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.09	CHEMBL4954	Homo sapiens	Inhibition	%	-0.09
	8136165	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.72	CHEMBL4954	Homo sapiens	Inhibition	%	1.72
	8136309	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	50.59	CHEMBL4954	Homo sapiens	Inhibition	%	50.59
	8136533	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.63	CHEMBL4954	Homo sapiens	Inhibition	%	3.63
	8136599	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.1	CHEMBL4954	Homo sapiens	Inhibition	%	-1.1
	8136823	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.2	CHEMBL4954	Homo sapiens	Inhibition	%	-3.2
	8136958	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.06	CHEMBL4954	Homo sapiens	Inhibition	%	3.06
	8137121	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.99	CHEMBL4954	Homo sapiens	Inhibition	%	1.99
	8137345	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.09	CHEMBL4954	Homo sapiens	Inhibition	%	3.09
	8137465	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.84	CHEMBL4954	Homo sapiens	Inhibition	%	3.84
	8137837	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.84	CHEMBL4954	Homo sapiens	Inhibition	%	2.84
	8138003	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-3.2	CHEMBL4954	Homo sapiens	Inhibition	%	-3.2
	8138406	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.99	CHEMBL4954	Homo sapiens	Inhibition	%	2.99
	8138554	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.59	CHEMBL4954	Homo sapiens	Inhibition	%	-2.59
	8138936	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.02	CHEMBL4954	Homo sapiens	Inhibition	%	2.02
	8139121	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-4.36	CHEMBL4954	Homo sapiens	Inhibition	%	-4.36
	8139504	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.9	CHEMBL4954	Homo sapiens	Inhibition	%	4.9
	8139618	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	8.45	CHEMBL4954	Homo sapiens	Inhibition	%	8.45
	8139983	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.19	CHEMBL4954	Homo sapiens	Inhibition	%	5.19
	8140330	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.21	CHEMBL4954	Homo sapiens	Inhibition	%	1.21
	8140489	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.83	CHEMBL4954	Homo sapiens	Inhibition	%	3.83
	8140856	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	10.31	CHEMBL4954	Homo sapiens	Inhibition	%	10.31
	8141158	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.13	CHEMBL4954	Homo sapiens	Inhibition	%	2.13
	8141288	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.8	CHEMBL4954	Homo sapiens	Inhibition	%	2.8
	8141672	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.12	CHEMBL4954	Homo sapiens	Inhibition	%	3.12
	8141791	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.95	CHEMBL4954	Homo sapiens	Inhibition	%	2.95
	8142015	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	16.06	CHEMBL4954	Homo sapiens	Inhibition	%	16.06
	8142176	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.04	CHEMBL4954	Homo sapiens	Inhibition	%	-1.04
	8142344	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.65	CHEMBL4954	Homo sapiens	Inhibition	%	-1.65
	8142568	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-6.9	CHEMBL4954	Homo sapiens	Inhibition	%	-6.9
	8142744	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.51	CHEMBL4954	Homo sapiens	Inhibition	%	3.51
	8142893	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-7.27	CHEMBL4954	Homo sapiens	Inhibition	%	-7.27
	8143117	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.99	CHEMBL4954	Homo sapiens	Inhibition	%	-6.99
	8143272	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.68	CHEMBL4954	Homo sapiens	Inhibition	%	3.68
	8143459	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.79	CHEMBL4954	Homo sapiens	Inhibition	%	1.79
	8143842	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.98	CHEMBL4954	Homo sapiens	Inhibition	%	5.98
	8143956	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.73	CHEMBL4954	Homo sapiens	Inhibition	%	2.73
	8144180	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.29	CHEMBL4954	Homo sapiens	Inhibition	%	1.29
	8144319	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.42	CHEMBL4954	Homo sapiens	Inhibition	%	2.42
	8144673	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.84	CHEMBL4954	Homo sapiens	Inhibition	%	2.84
	8144826	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.55	CHEMBL4954	Homo sapiens	Inhibition	%	2.55
	8145187	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.61	CHEMBL4954	Homo sapiens	Inhibition	%	4.61
	8145500	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.93	CHEMBL4954	Homo sapiens	Inhibition	%	0.93
	8145624	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.58	CHEMBL4954	Homo sapiens	Inhibition	%	1.58
	8145848	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.28	CHEMBL4954	Homo sapiens	Inhibition	%	2.28
	8146009	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	7.33	CHEMBL4954	Homo sapiens	Inhibition	%	7.33
	8146353	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	9.91	CHEMBL4954	Homo sapiens	Inhibition	%	9.91
	8146513	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.38	CHEMBL4954	Homo sapiens	Inhibition	%	0.38
	8146904	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.01	CHEMBL4954	Homo sapiens	Inhibition	%	-0.01
	8147073	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.14	CHEMBL4954	Homo sapiens	Inhibition	%	1.14
	8147439	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.67	CHEMBL4954	Homo sapiens	Inhibition	%	2.67
	8147592	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.02	CHEMBL4954	Homo sapiens	Inhibition	%	3.02
	8147779	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.64	CHEMBL4954	Homo sapiens	Inhibition	%	4.64
	8148003	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.28	CHEMBL4954	Homo sapiens	Inhibition	%	0.28
	8148161	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	15.06	CHEMBL4954	Homo sapiens	Inhibition	%	15.06
	8148499	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.45	CHEMBL4954	Homo sapiens	Inhibition	%	1.45
	8148638	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.7	CHEMBL4954	Homo sapiens	Inhibition	%	2.7
	8148862	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.81	CHEMBL4954	Homo sapiens	Inhibition	%	3.81
	8149000	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.37	CHEMBL4954	Homo sapiens	Inhibition	%	2.37
	8149159	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.23	CHEMBL4954	Homo sapiens	Inhibition	%	2.23
	8149383	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.74	CHEMBL4954	Homo sapiens	Inhibition	%	-2.74
	8149517	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.18	CHEMBL4954	Homo sapiens	Inhibition	%	6.18
	8149839	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	7.72	CHEMBL4954	Homo sapiens	Inhibition	%	7.72
	8150188	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.15	CHEMBL4954	Homo sapiens	Inhibition	%	4.15
	8150348	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	7.13	CHEMBL4954	Homo sapiens	Inhibition	%	7.13
	8150692	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	34.54	CHEMBL4954	Homo sapiens	Inhibition	%	34.54
	8150857	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.88	CHEMBL4954	Homo sapiens	Inhibition	%	1.88
	8151244	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-6.73	CHEMBL4954	Homo sapiens	Inhibition	%	-6.73
	8151421	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.96	CHEMBL4954	Homo sapiens	Inhibition	%	3.96
	8151783	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.91	CHEMBL4954	Homo sapiens	Inhibition	%	3.91
	8151937	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.37	CHEMBL4954	Homo sapiens	Inhibition	%	4.37
	8152161	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.21	CHEMBL4954	Homo sapiens	Inhibition	%	5.21
	8152349	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.62	CHEMBL4954	Homo sapiens	Inhibition	%	4.62
	8152507	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.55	CHEMBL4954	Homo sapiens	Inhibition	%	3.55
	8152845	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.4	CHEMBL4954	Homo sapiens	Inhibition	%	4.4
	8153208	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.75	CHEMBL4954	Homo sapiens	Inhibition	%	2.75
	8153345	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.3	CHEMBL4954	Homo sapiens	Inhibition	%	5.3
	8153726	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.11	CHEMBL4954	Homo sapiens	Inhibition	%	-2.11
	8153859	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.15	CHEMBL4954	Homo sapiens	Inhibition	%	1.15
	8154083	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.09	CHEMBL4954	Homo sapiens	Inhibition	%	5.09
	8154180	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	17.62	CHEMBL4954	Homo sapiens	Inhibition	%	17.62
	8154530	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	15.88	CHEMBL4954	Homo sapiens	Inhibition	%	15.88
	8154689	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.08	CHEMBL4954	Homo sapiens	Inhibition	%	1.08
	8154913	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.39	CHEMBL4954	Homo sapiens	Inhibition	%	0.39
	8155033	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	4.32	CHEMBL4954	Homo sapiens	Inhibition	%	4.32
	8155209	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.28	CHEMBL4954	Homo sapiens	Inhibition	%	-0.28
	8155433	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.75	CHEMBL4954	Homo sapiens	Inhibition	%	0.75
	8155594	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-6.53	CHEMBL4954	Homo sapiens	Inhibition	%	-6.53
	8155772	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.4	CHEMBL4954	Homo sapiens	Inhibition	%	2.4
	8155996	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.87	CHEMBL4954	Homo sapiens	Inhibition	%	3.87
	8156134	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.59	CHEMBL4954	Homo sapiens	Inhibition	%	1.59
	8156346	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.27	CHEMBL4954	Homo sapiens	Inhibition	%	3.27
	8156570	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.73	CHEMBL4954	Homo sapiens	Inhibition	%	3.73
	8156720	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.85	CHEMBL4954	Homo sapiens	Inhibition	%	6.85
	8156863	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.94	CHEMBL4954	Homo sapiens	Inhibition	%	2.94
	8157087	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.57	CHEMBL4954	Homo sapiens	Inhibition	%	4.57
	8157207	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.71	CHEMBL4954	Homo sapiens	Inhibition	%	2.71
	8157572	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.02	CHEMBL4954	Homo sapiens	Inhibition	%	6.02
	8157702	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.94	CHEMBL4954	Homo sapiens	Inhibition	%	8.94
	8157926	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.37	CHEMBL4954	Homo sapiens	Inhibition	%	3.37
	8158087	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.08	CHEMBL4954	Homo sapiens	Inhibition	%	0.08
	8158337	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.83	CHEMBL4954	Homo sapiens	Inhibition	%	3.83
	8158719	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.25	CHEMBL4954	Homo sapiens	Inhibition	%	-0.25
	8158888	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.66	CHEMBL4954	Homo sapiens	Inhibition	%	1.66
	8159247	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.97	CHEMBL4954	Homo sapiens	Inhibition	%	5.97
	8159367	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.48	CHEMBL4954	Homo sapiens	Inhibition	%	2.48
	8159591	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.6	CHEMBL4954	Homo sapiens	Inhibition	%	-0.6
	8159722	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.36	CHEMBL4954	Homo sapiens	Inhibition	%	6.36
	8160087	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.96	CHEMBL4954	Homo sapiens	Inhibition	%	1.96
	8160224	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.54	CHEMBL4954	Homo sapiens	Inhibition	%	5.54
	8160598	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-4.93	CHEMBL4954	Homo sapiens	Inhibition	%	-4.93
	8160892	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.51	CHEMBL4954	Homo sapiens	Inhibition	%	5.51
	8161042	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.27	CHEMBL4954	Homo sapiens	Inhibition	%	4.27
	8161409	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.54	CHEMBL4954	Homo sapiens	Inhibition	%	7.54
	8161534	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.28	CHEMBL4954	Homo sapiens	Inhibition	%	2.28
	8161758	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.51	CHEMBL4954	Homo sapiens	Inhibition	%	2.51
	8161896	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.71	CHEMBL4954	Homo sapiens	Inhibition	%	10.71
	8162250	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.46	CHEMBL4954	Homo sapiens	Inhibition	%	4.46
	8162410	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.6	CHEMBL4954	Homo sapiens	Inhibition	%	-0.6
	8162663	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.99	CHEMBL4954	Homo sapiens	Inhibition	%	4.99
	8163035	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.57	CHEMBL4954	Homo sapiens	Inhibition	%	5.57
	8163204	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.19	CHEMBL4954	Homo sapiens	Inhibition	%	4.19
	8163562	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.01	CHEMBL4954	Homo sapiens	Inhibition	%	4.01
	8163909	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.35	CHEMBL4954	Homo sapiens	Inhibition	%	0.35
	8164043	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.86	CHEMBL4954	Homo sapiens	Inhibition	%	3.86
	8164407	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.75	CHEMBL4954	Homo sapiens	Inhibition	%	-0.75
	8164562	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.42	CHEMBL4954	Homo sapiens	Inhibition	%	6.42
	8164930	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.48	CHEMBL4954	Homo sapiens	Inhibition	%	-1.48
	8165224	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.44	CHEMBL4954	Homo sapiens	Inhibition	%	5.44
	8165365	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.54	CHEMBL4954	Homo sapiens	Inhibition	%	5.54
	8165589	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.8	CHEMBL4954	Homo sapiens	Inhibition	%	1.8
	8165732	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	5.48	CHEMBL4954	Homo sapiens	Inhibition	%	5.48
	8166082	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.67	CHEMBL4954	Homo sapiens	Inhibition	%	2.67
	8166220	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.22	CHEMBL4954	Homo sapiens	Inhibition	%	4.22
	8166574	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	7.79	CHEMBL4954	Homo sapiens	Inhibition	%	7.79
	8166899	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	15.26	CHEMBL4954	Homo sapiens	Inhibition	%	15.26
	8166987	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.74	CHEMBL4954	Homo sapiens	Inhibition	%	5.74
	8167211	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.26	CHEMBL4954	Homo sapiens	Inhibition	%	3.26
	8167352	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	12.79	CHEMBL4954	Homo sapiens	Inhibition	%	12.79
	8167516	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.05	CHEMBL4954	Homo sapiens	Inhibition	%	2.05
	8167740	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.38	CHEMBL4954	Homo sapiens	Inhibition	%	4.38
	8167873	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.17	CHEMBL4954	Homo sapiens	Inhibition	%	4.17
	8168221	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.51	CHEMBL4954	Homo sapiens	Inhibition	%	2.51
	8168362	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.27	CHEMBL4954	Homo sapiens	Inhibition	%	4.27
	8168586	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.24	CHEMBL4954	Homo sapiens	Inhibition	%	5.24
	8168722	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.11	CHEMBL4954	Homo sapiens	Inhibition	%	-0.11
	8168886	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.11	CHEMBL4954	Homo sapiens	Inhibition	%	8.11
	8169110	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	19.24	CHEMBL4954	Homo sapiens	Inhibition	%	19.24
	8169252	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.15	CHEMBL4954	Homo sapiens	Inhibition	%	5.15
	8169556	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.06	CHEMBL4954	Homo sapiens	Inhibition	%	5.06
	8169914	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.6	CHEMBL4954	Homo sapiens	Inhibition	%	3.6
	8170059	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	6.5	CHEMBL4954	Homo sapiens	Inhibition	%	6.5
	8170408	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.1	CHEMBL4954	Homo sapiens	Inhibition	%	4.1
	8170548	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.16	CHEMBL4954	Homo sapiens	Inhibition	%	4.16
	8170772	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.49	CHEMBL4954	Homo sapiens	Inhibition	%	-0.49
	8170907	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.42	CHEMBL4954	Homo sapiens	Inhibition	%	6.42
	8171104	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.47	CHEMBL4954	Homo sapiens	Inhibition	%	-0.47
	8171328	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	6.23	CHEMBL4954	Homo sapiens	Inhibition	%	6.23
	8171545	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.85	CHEMBL4954	Homo sapiens	Inhibition	%	4.85
	8171686	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.65	CHEMBL4954	Homo sapiens	Inhibition	%	4.65
	8172063	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.03	CHEMBL4954	Homo sapiens	Inhibition	%	-1.03
	8172195	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.99	CHEMBL4954	Homo sapiens	Inhibition	%	4.99
	8172419	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.7	CHEMBL4954	Homo sapiens	Inhibition	%	5.7
	8172547	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.14	CHEMBL4954	Homo sapiens	Inhibition	%	2.14
	8172913	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.21	CHEMBL4954	Homo sapiens	Inhibition	%	7.21
	8173049	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-5.8	CHEMBL4954	Homo sapiens	Inhibition	%	-5.8
	8173438	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.89	CHEMBL4954	Homo sapiens	Inhibition	%	5.89
	8173579	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.1	CHEMBL4954	Homo sapiens	Inhibition	%	4.1
	8173803	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.82	CHEMBL4954	Homo sapiens	Inhibition	%	4.82
	8173890	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.18	CHEMBL4954	Homo sapiens	Inhibition	%	7.18
	8174246	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.42	CHEMBL4954	Homo sapiens	Inhibition	%	7.42
	8174394	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	14.59	CHEMBL4954	Homo sapiens	Inhibition	%	14.59
	8174618	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.75	CHEMBL4954	Homo sapiens	Inhibition	%	2.75
	8174740	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.43	CHEMBL4954	Homo sapiens	Inhibition	%	3.43
	8175107	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.92	CHEMBL4954	Homo sapiens	Inhibition	%	-1.92
	8175243	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.96	CHEMBL4954	Homo sapiens	Inhibition	%	1.96
	8175499	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.74	CHEMBL4954	Homo sapiens	Inhibition	%	2.74
	8175723	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.04	CHEMBL4954	Homo sapiens	Inhibition	%	4.04
	8175886	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.82	CHEMBL4954	Homo sapiens	Inhibition	%	6.82
	8176039	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.34	CHEMBL4954	Homo sapiens	Inhibition	%	4.34
	8176263	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.0	CHEMBL4954	Homo sapiens	Inhibition	%	7.0
	8176412	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.95	CHEMBL4954	Homo sapiens	Inhibition	%	-0.95
	8176768	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.27	CHEMBL4954	Homo sapiens	Inhibition	%	9.27
	8176898	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-1.82	CHEMBL4954	Homo sapiens	Inhibition	%	-1.82
	8177264	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	12.38	CHEMBL4954	Homo sapiens	Inhibition	%	12.38
	8177402	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.02	CHEMBL4954	Homo sapiens	Inhibition	%	-2.02
	8177626	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.78	CHEMBL4954	Homo sapiens	Inhibition	%	5.78
	8177790	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.97	CHEMBL4954	Homo sapiens	Inhibition	%	6.97
	8178154	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.94	CHEMBL4954	Homo sapiens	Inhibition	%	3.94
	8178242	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.06	CHEMBL4954	Homo sapiens	Inhibition	%	8.06
	8178466	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.97	CHEMBL4954	Homo sapiens	Inhibition	%	2.97
	8178593	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	16.19	CHEMBL4954	Homo sapiens	Inhibition	%	16.19
	8178966	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.67	CHEMBL4954	Homo sapiens	Inhibition	%	4.67
	8179089	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	6.99	CHEMBL4954	Homo sapiens	Inhibition	%	6.99
	8179457	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.4	CHEMBL4954	Homo sapiens	Inhibition	%	4.4
	8179594	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.55	CHEMBL4954	Homo sapiens	Inhibition	%	4.55
	8179818	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.56	CHEMBL4954	Homo sapiens	Inhibition	%	2.56
	8180075	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.03	CHEMBL4954	Homo sapiens	Inhibition	%	4.03
	8180229	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	16.5	CHEMBL4954	Homo sapiens	Inhibition	%	16.5
	8180609	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.64	CHEMBL4954	Homo sapiens	Inhibition	%	4.64
	8180757	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.63	CHEMBL4954	Homo sapiens	Inhibition	%	2.63
	8181114	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	92.25	CHEMBL4954	Homo sapiens	Inhibition	%	92.25
	8181245	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.58	CHEMBL4954	Homo sapiens	Inhibition	%	0.58
	8181469	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-8.6	CHEMBL4954	Homo sapiens	Inhibition	%	-8.6
	8181609	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	34.84	CHEMBL4954	Homo sapiens	Inhibition	%	34.84
	8181972	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.32	CHEMBL4954	Homo sapiens	Inhibition	%	6.32
	8182135	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.86	CHEMBL4954	Homo sapiens	Inhibition	%	5.86
	8182499	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.83	CHEMBL4954	Homo sapiens	Inhibition	%	2.83
	8182815	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.79	CHEMBL4954	Homo sapiens	Inhibition	%	4.79
	8182937	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.05	CHEMBL4954	Homo sapiens	Inhibition	%	4.05
	8183310	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.57	CHEMBL4954	Homo sapiens	Inhibition	%	5.57
	8183439	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.34	CHEMBL4954	Homo sapiens	Inhibition	%	4.34
	8183663	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.34	CHEMBL4954	Homo sapiens	Inhibition	%	0.34
	8183805	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.58	CHEMBL4954	Homo sapiens	Inhibition	%	3.58
	8184165	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.25	CHEMBL4954	Homo sapiens	Inhibition	%	2.25
	8184431	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.66	CHEMBL4954	Homo sapiens	Inhibition	%	2.66
	8184578	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.97	CHEMBL4954	Homo sapiens	Inhibition	%	-1.97
	8184802	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.94	CHEMBL4954	Homo sapiens	Inhibition	%	-0.94
	8184959	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	7.69	CHEMBL4954	Homo sapiens	Inhibition	%	7.69
	8185108	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.13	CHEMBL4954	Homo sapiens	Inhibition	%	3.13
	8185332	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.09	CHEMBL4954	Homo sapiens	Inhibition	%	-2.09
	8185463	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	81.47	CHEMBL4954	Homo sapiens	Inhibition	%	81.47
	8185818	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.74	CHEMBL4954	Homo sapiens	Inhibition	%	-1.74
	8185957	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.17	CHEMBL4954	Homo sapiens	Inhibition	%	5.17
	8186181	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.3	CHEMBL4954	Homo sapiens	Inhibition	%	6.3
	8186322	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.49	CHEMBL4954	Homo sapiens	Inhibition	%	3.49
	8186486	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.22	CHEMBL4954	Homo sapiens	Inhibition	%	6.22
	8186710	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.52	CHEMBL4954	Homo sapiens	Inhibition	%	7.52
	8186849	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.84	CHEMBL4954	Homo sapiens	Inhibition	%	3.84
	8187171	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.13	CHEMBL4954	Homo sapiens	Inhibition	%	5.13
	8187295	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.06	CHEMBL4954	Homo sapiens	Inhibition	%	4.06
	8187519	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.89	CHEMBL4954	Homo sapiens	Inhibition	%	6.89
	8187667	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	8.5	CHEMBL4954	Homo sapiens	Inhibition	%	8.5
	8188020	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.49	CHEMBL4954	Homo sapiens	Inhibition	%	2.49
	8188163	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.83	CHEMBL4954	Homo sapiens	Inhibition	%	4.83
	8188387	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.35	CHEMBL4954	Homo sapiens	Inhibition	%	4.35
	8188522	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-2.15	CHEMBL4954	Homo sapiens	Inhibition	%	-2.15
	8188796	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.84	CHEMBL4954	Homo sapiens	Inhibition	%	5.84
	8189168	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.55	CHEMBL4954	Homo sapiens	Inhibition	%	3.55
	8189324	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	18.19	CHEMBL4954	Homo sapiens	Inhibition	%	18.19
	8189697	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.64	CHEMBL4954	Homo sapiens	Inhibition	%	0.64
	8189829	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.3	CHEMBL4954	Homo sapiens	Inhibition	%	1.3
	8190185	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.45	CHEMBL4954	Homo sapiens	Inhibition	%	4.45
	8190549	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.37	CHEMBL4954	Homo sapiens	Inhibition	%	5.37
	8190686	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.3	CHEMBL4954	Homo sapiens	Inhibition	%	6.3
	8191074	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.91	CHEMBL4954	Homo sapiens	Inhibition	%	5.91
	8191212	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.79	CHEMBL4954	Homo sapiens	Inhibition	%	3.79
	8191532	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	19.54	CHEMBL4954	Homo sapiens	Inhibition	%	19.54
	8191878	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.93	CHEMBL4954	Homo sapiens	Inhibition	%	7.93
	8192027	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.96	CHEMBL4954	Homo sapiens	Inhibition	%	2.96
	8192251	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.85	CHEMBL4954	Homo sapiens	Inhibition	%	2.85
	8192380	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.41	CHEMBL4954	Homo sapiens	Inhibition	%	1.41
	8192748	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.53	CHEMBL4954	Homo sapiens	Inhibition	%	6.53
	8192884	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.2	CHEMBL4954	Homo sapiens	Inhibition	%	-1.2
	8193156	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.64	CHEMBL4954	Homo sapiens	Inhibition	%	3.64
	8193525	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.89	CHEMBL4954	Homo sapiens	Inhibition	%	7.89
	8193682	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.01	CHEMBL4954	Homo sapiens	Inhibition	%	3.01
	8193906	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.78	CHEMBL4954	Homo sapiens	Inhibition	%	3.78
	8194055	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-5.79	CHEMBL4954	Homo sapiens	Inhibition	%	-5.79
	8194186	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.15	CHEMBL4954	Homo sapiens	Inhibition	%	5.15
	8194410	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.24	CHEMBL4954	Homo sapiens	Inhibition	%	6.24
	8194541	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.49	CHEMBL4954	Homo sapiens	Inhibition	%	5.49
	8194908	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	8.77	CHEMBL4954	Homo sapiens	Inhibition	%	8.77
	8195041	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.3	CHEMBL4954	Homo sapiens	Inhibition	%	5.3
	8195265	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.33	CHEMBL4954	Homo sapiens	Inhibition	%	5.33
	8195429	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.92	CHEMBL4954	Homo sapiens	Inhibition	%	2.92
	8195568	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.33	CHEMBL4954	Homo sapiens	Inhibition	%	4.33
	8195792	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.06	CHEMBL4954	Homo sapiens	Inhibition	%	6.06
	8195890	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.49	CHEMBL4954	Homo sapiens	Inhibition	%	3.49
	8196231	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.49	CHEMBL4954	Homo sapiens	Inhibition	%	4.49
	8196605	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	9.53	CHEMBL4954	Homo sapiens	Inhibition	%	9.53
	8196733	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.21	CHEMBL4954	Homo sapiens	Inhibition	%	4.21
	8197098	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.47	CHEMBL4954	Homo sapiens	Inhibition	%	6.47
	8197235	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.82	CHEMBL4954	Homo sapiens	Inhibition	%	-0.82
	8197459	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.98	CHEMBL4954	Homo sapiens	Inhibition	%	1.98
	8197510	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.53	CHEMBL4954	Homo sapiens	Inhibition	%	4.53
	8197734	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.83	CHEMBL4954	Homo sapiens	Inhibition	%	2.83
	8197874	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-1.62	CHEMBL4954	Homo sapiens	Inhibition	%	-1.62
	8198255	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.22	CHEMBL4954	Homo sapiens	Inhibition	%	-0.22
	8198393	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.29	CHEMBL4954	Homo sapiens	Inhibition	%	-2.29
	8198747	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	16.73	CHEMBL4954	Homo sapiens	Inhibition	%	16.73
	8198878	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.76	CHEMBL4954	Homo sapiens	Inhibition	%	3.76
	8199102	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.61	CHEMBL4954	Homo sapiens	Inhibition	%	3.61
	8199250	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.81	CHEMBL4954	Homo sapiens	Inhibition	%	7.81
	8199608	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.46	CHEMBL4954	Homo sapiens	Inhibition	%	4.46
	8199771	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.1	CHEMBL4954	Homo sapiens	Inhibition	%	6.1
	8200133	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.97	CHEMBL4954	Homo sapiens	Inhibition	%	6.97
	8200237	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.54	CHEMBL4954	Homo sapiens	Inhibition	%	3.54
	8200461	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.69	CHEMBL4954	Homo sapiens	Inhibition	%	1.69
	8200576	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.41	CHEMBL4954	Homo sapiens	Inhibition	%	4.41
	8200950	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	18.1	CHEMBL4954	Homo sapiens	Inhibition	%	18.1
	8201080	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.47	CHEMBL4954	Homo sapiens	Inhibition	%	-2.47
	8201304	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.85	CHEMBL4954	Homo sapiens	Inhibition	%	0.85
	8201439	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.29	CHEMBL4954	Homo sapiens	Inhibition	%	2.29
	8201796	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.34	CHEMBL4954	Homo sapiens	Inhibition	%	-1.34
	8202075	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.24	CHEMBL4954	Homo sapiens	Inhibition	%	3.24
	8202215	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.98	CHEMBL4954	Homo sapiens	Inhibition	%	0.98
	8202606	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.79	CHEMBL4954	Homo sapiens	Inhibition	%	-0.79
	8202731	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.9	CHEMBL4954	Homo sapiens	Inhibition	%	3.9
	8202955	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.31	CHEMBL4954	Homo sapiens	Inhibition	%	4.31
	8203085	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.11	CHEMBL4954	Homo sapiens	Inhibition	%	6.11
	8203440	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.79	CHEMBL4954	Homo sapiens	Inhibition	%	0.79
	8203586	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.67	CHEMBL4954	Homo sapiens	Inhibition	%	5.67
	8203944	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.68	CHEMBL4954	Homo sapiens	Inhibition	%	4.68
	8204110	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	11.19	CHEMBL4954	Homo sapiens	Inhibition	%	11.19
	8204334	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	22.42	CHEMBL4954	Homo sapiens	Inhibition	%	22.42
	8204471	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	79.33	CHEMBL4954	Homo sapiens	Inhibition	%	79.33
	8204800	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.97	CHEMBL4954	Homo sapiens	Inhibition	%	7.97
	8204915	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.55	CHEMBL4954	Homo sapiens	Inhibition	%	5.55
	8205139	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	16.48	CHEMBL4954	Homo sapiens	Inhibition	%	16.48
	8205288	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.23	CHEMBL4954	Homo sapiens	Inhibition	%	5.23
	8205648	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.43	CHEMBL4954	Homo sapiens	Inhibition	%	2.43
	8205787	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.77	CHEMBL4954	Homo sapiens	Inhibition	%	3.77
	8206143	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.2	CHEMBL4954	Homo sapiens	Inhibition	%	-0.2
	8206419	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.95	CHEMBL4954	Homo sapiens	Inhibition	%	1.95
	8206562	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-6.05	CHEMBL4954	Homo sapiens	Inhibition	%	-6.05
	8206786	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.41	CHEMBL4954	Homo sapiens	Inhibition	%	-2.41
	8206966	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.17	CHEMBL4954	Homo sapiens	Inhibition	%	4.17
	8207316	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.59	CHEMBL4954	Homo sapiens	Inhibition	%	4.59
	8207446	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.22	CHEMBL4954	Homo sapiens	Inhibition	%	5.22
	8207802	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.97	CHEMBL4954	Homo sapiens	Inhibition	%	2.97
	8207947	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.9	CHEMBL4954	Homo sapiens	Inhibition	%	2.9
	8208171	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.16	CHEMBL4954	Homo sapiens	Inhibition	%	6.16
	8208303	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.5	CHEMBL4954	Homo sapiens	Inhibition	%	4.5
	8208693	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.77	CHEMBL4954	Homo sapiens	Inhibition	%	3.77
	8208826	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	87.51	CHEMBL4954	Homo sapiens	Inhibition	%	87.51
	8209155	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-1.38	CHEMBL4954	Homo sapiens	Inhibition	%	-1.38
	8209495	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.58	CHEMBL4954	Homo sapiens	Inhibition	%	2.58
	8209645	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.8	CHEMBL4954	Homo sapiens	Inhibition	%	5.8
	8210005	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.98	CHEMBL4954	Homo sapiens	Inhibition	%	6.98
	8210146	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.45	CHEMBL4954	Homo sapiens	Inhibition	%	3.45
	8210370	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.59	CHEMBL4954	Homo sapiens	Inhibition	%	4.59
	8210506	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-7.71	CHEMBL4954	Homo sapiens	Inhibition	%	-7.71
	8210765	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.26	CHEMBL4954	Homo sapiens	Inhibition	%	-0.26
	8211133	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.53	CHEMBL4954	Homo sapiens	Inhibition	%	4.53
	8211303	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.42	CHEMBL4954	Homo sapiens	Inhibition	%	5.42
	8211650	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.27	CHEMBL4954	Homo sapiens	Inhibition	%	4.27
	8211779	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.45	CHEMBL4954	Homo sapiens	Inhibition	%	8.45
	8212003	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	13.98	CHEMBL4954	Homo sapiens	Inhibition	%	13.98
	8212135	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.7	CHEMBL4954	Homo sapiens	Inhibition	%	2.7
	8212500	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.89	CHEMBL4954	Homo sapiens	Inhibition	%	2.89
	8212633	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.51	CHEMBL4954	Homo sapiens	Inhibition	%	7.51
	8212857	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.76	CHEMBL4954	Homo sapiens	Inhibition	%	5.76
	8213027	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.3	CHEMBL4954	Homo sapiens	Inhibition	%	6.3
	8213156	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.71	CHEMBL4954	Homo sapiens	Inhibition	%	3.71
	8213380	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.7	CHEMBL4954	Homo sapiens	Inhibition	%	3.7
	8213484	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	4.18	CHEMBL4954	Homo sapiens	Inhibition	%	4.18
	8213821	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.28	CHEMBL4954	Homo sapiens	Inhibition	%	3.28
	8213968	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.34	CHEMBL4954	Homo sapiens	Inhibition	%	2.34
	8214192	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.31	CHEMBL4954	Homo sapiens	Inhibition	%	2.31
	8214329	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.58	CHEMBL4954	Homo sapiens	Inhibition	%	3.58
	8214687	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	14.26	CHEMBL4954	Homo sapiens	Inhibition	%	14.26
	8214839	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.29	CHEMBL4954	Homo sapiens	Inhibition	%	-2.29
	8215090	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.93	CHEMBL4954	Homo sapiens	Inhibition	%	-1.93
	8215314	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.74	CHEMBL4954	Homo sapiens	Inhibition	%	0.74
	8215467	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.54	CHEMBL4954	Homo sapiens	Inhibition	%	3.54
	8215631	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.84	CHEMBL4954	Homo sapiens	Inhibition	%	4.84
	8215855	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.4	CHEMBL4954	Homo sapiens	Inhibition	%	4.4
	8215974	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.19	CHEMBL4954	Homo sapiens	Inhibition	%	0.19
	8216317	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.19	CHEMBL4954	Homo sapiens	Inhibition	%	2.19
	8216453	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.87	CHEMBL4954	Homo sapiens	Inhibition	%	3.87
	8216677	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.06	CHEMBL4954	Homo sapiens	Inhibition	%	6.06
	8216815	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.36	CHEMBL4954	Homo sapiens	Inhibition	%	4.36
	8217173	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.16	CHEMBL4954	Homo sapiens	Inhibition	%	6.16
	8217347	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.07	CHEMBL4954	Homo sapiens	Inhibition	%	2.07
	8217702	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.09	CHEMBL4954	Homo sapiens	Inhibition	%	8.09
	8217803	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.17	CHEMBL4954	Homo sapiens	Inhibition	%	-3.17
	8218027	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.69	CHEMBL4954	Homo sapiens	Inhibition	%	-3.69
	8218142	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.42	CHEMBL4954	Homo sapiens	Inhibition	%	2.42
	8218493	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.11	CHEMBL4954	Homo sapiens	Inhibition	%	3.11
	8218636	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	14.32	CHEMBL4954	Homo sapiens	Inhibition	%	14.32
	8218991	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	33.88	CHEMBL4954	Homo sapiens	Inhibition	%	33.88
	8219151	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.39	CHEMBL4954	Homo sapiens	Inhibition	%	-1.39
	8219375	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.22	CHEMBL4954	Homo sapiens	Inhibition	%	-0.22
	8219625	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.02	CHEMBL4954	Homo sapiens	Inhibition	%	3.02
	8219786	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.58	CHEMBL4954	Homo sapiens	Inhibition	%	2.58
	8220179	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.48	CHEMBL4954	Homo sapiens	Inhibition	%	5.48
	8220308	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.58	CHEMBL4954	Homo sapiens	Inhibition	%	-0.58
	8220646	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.58	CHEMBL4954	Homo sapiens	Inhibition	%	5.58
	8221008	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.39	CHEMBL4954	Homo sapiens	Inhibition	%	4.39
	8221144	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.91	CHEMBL4954	Homo sapiens	Inhibition	%	-1.91
	8221501	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.98	CHEMBL4954	Homo sapiens	Inhibition	%	2.98
	8221666	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.91	CHEMBL4954	Homo sapiens	Inhibition	%	2.91
	8222021	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	13.64	CHEMBL4954	Homo sapiens	Inhibition	%	13.64
	8222343	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.51	CHEMBL4954	Homo sapiens	Inhibition	%	3.51
	8222477	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.57	CHEMBL4954	Homo sapiens	Inhibition	%	3.57
	8222819	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.35	CHEMBL4954	Homo sapiens	Inhibition	%	6.35
	8222963	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	82.11	CHEMBL4954	Homo sapiens	Inhibition	%	82.11
	8223187	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.14	CHEMBL4954	Homo sapiens	Inhibition	%	87.14
	8223316	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.22	CHEMBL4954	Homo sapiens	Inhibition	%	4.22
	8223701	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.07	CHEMBL4954	Homo sapiens	Inhibition	%	-0.07
	8223951	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.84	CHEMBL4954	Homo sapiens	Inhibition	%	4.84
	8224113	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.4	CHEMBL4954	Homo sapiens	Inhibition	%	3.4
	8224337	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.85	CHEMBL4954	Homo sapiens	Inhibition	%	-0.85
	8224507	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.94	CHEMBL4954	Homo sapiens	Inhibition	%	4.94
	8224642	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.39	CHEMBL4954	Homo sapiens	Inhibition	%	2.39
	8224866	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.68	CHEMBL4954	Homo sapiens	Inhibition	%	3.68
	8224980	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.24	CHEMBL4954	Homo sapiens	Inhibition	%	2.24
	8225338	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.18	CHEMBL4954	Homo sapiens	Inhibition	%	6.18
	8225476	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.81	CHEMBL4954	Homo sapiens	Inhibition	%	-1.81
	8225700	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.11	CHEMBL4954	Homo sapiens	Inhibition	%	-0.11
	8225835	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.01	CHEMBL4954	Homo sapiens	Inhibition	%	6.01
	8225993	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.55	CHEMBL4954	Homo sapiens	Inhibition	%	-0.55
	8226217	CHEMBL1962271	GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.63	CHEMBL4954	Homo sapiens	Inhibition	%	1.63
	8226342	CHEMBL1962270	GSK_PKIS: EPHA3 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.8	CHEMBL4954	Homo sapiens	Inhibition	%	1.8
	10838569	CHEMBL2014142	Inhibition of EPHA3 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4954	Homo sapiens	INH	%	0.0
	10978475	CHEMBL2066232	Inhibition of human recombinant EphA3 using ulight-TK peptide as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL4954	Homo sapiens	Activity	%	80.0
	10991134	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070045	=	IC50	nM	1600.0	CHEMBL4954	Homo sapiens	IC50	uM	1.6
	10991135	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070047	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	10991136	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070048	=	IC50	nM	3700.0	CHEMBL4954	Homo sapiens	IC50	uM	3.7
	10991137	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070050	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	10991138	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2n1.Cl		CHEMBL2070051	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	10991139	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	CCOc1ccc2cc(-c3nn(C4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070075	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	10991140	CHEMBL2072947	Inhibition of human EPHA3 using myelin basic protein as substrate after 120 mins	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070081	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	12074628	CHEMBL2161025	Inhibition of EphA3 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	12173638	CHEMBL2214014	Inhibition of EPHA3 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	61.0	CHEMBL4954	Homo sapiens	Activity	%	61.0
	12183892	CHEMBL2211495	Inhibition of EPHA3	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	pIC50		5.0
	12195579	CHEMBL2211364	Inhibition of human recombinant EPHA3 using Ulight-TK peptide as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	101.3	CHEMBL4954	Homo sapiens	Activity	%	101.3
	12244910	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	122.0	CHEMBL4954	Homo sapiens	Residual Activity	%	122.0
	12244911	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	109.0	CHEMBL4954	Homo sapiens	Residual Activity	%	109.0
	12244912	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	115.0	CHEMBL4954	Homo sapiens	Residual Activity	%	115.0
	12244913	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12244914	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	93.0	CHEMBL4954	Homo sapiens	Residual Activity	%	93.0
	12244915	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12244916	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	50.0	CHEMBL4954	Homo sapiens	Residual Activity	%	50.0
	12244917	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	95.0	CHEMBL4954	Homo sapiens	Residual Activity	%	95.0
	12244918	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	127.0	CHEMBL4954	Homo sapiens	Residual Activity	%	127.0
	12244919	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12244920	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	113.0	CHEMBL4954	Homo sapiens	Residual Activity	%	113.0
	12244921	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	104.0	CHEMBL4954	Homo sapiens	Residual Activity	%	104.0
	12244922	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12244923	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	63.0	CHEMBL4954	Homo sapiens	Residual Activity	%	63.0
	12244924	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12244925	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	111.0	CHEMBL4954	Homo sapiens	Residual Activity	%	111.0
	12244926	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	116.0	CHEMBL4954	Homo sapiens	Residual Activity	%	116.0
	12244927	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	115.0	CHEMBL4954	Homo sapiens	Residual Activity	%	115.0
	12244928	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12244929	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12244930	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12244931	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	104.0	CHEMBL4954	Homo sapiens	Residual Activity	%	104.0
	12244932	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	115.0	CHEMBL4954	Homo sapiens	Residual Activity	%	115.0
	12244933	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	113.0	CHEMBL4954	Homo sapiens	Residual Activity	%	113.0
	12244934	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	119.0	CHEMBL4954	Homo sapiens	Residual Activity	%	119.0
	12244935	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	81.0	CHEMBL4954	Homo sapiens	Residual Activity	%	81.0
	12244936	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12244937	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	79.0	CHEMBL4954	Homo sapiens	Residual Activity	%	79.0
	12244938	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12244939	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL4954	Homo sapiens	Residual Activity	%	89.0
	12244940	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12244941	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL4954	Homo sapiens	Residual Activity	%	1.0
	12244942	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL4954	Homo sapiens	Residual Activity	%	112.0
	12244943	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12244944	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4954	Homo sapiens	Residual Activity	%	108.0
	12244945	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12244946	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12244947	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12244948	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12244949	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL4954	Homo sapiens	Residual Activity	%	108.0
	12244950	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	113.0	CHEMBL4954	Homo sapiens	Residual Activity	%	113.0
	12244951	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12244952	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12244953	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12244954	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12244955	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12244956	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12244957	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12244958	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	113.0	CHEMBL4954	Homo sapiens	Residual Activity	%	113.0
	12247554	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	114.0	CHEMBL4954	Homo sapiens	Residual Activity	%	114.0
	12247555	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247556	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247557	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	82.0	CHEMBL4954	Homo sapiens	Residual Activity	%	82.0
	12247558	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247559	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12247560	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247561	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	112.0	CHEMBL4954	Homo sapiens	Residual Activity	%	112.0
	12247562	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	109.0	CHEMBL4954	Homo sapiens	Residual Activity	%	109.0
	12247563	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247564	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247565	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12247566	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247567	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12247568	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247569	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL4954	Homo sapiens	Residual Activity	%	116.0
	12247570	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247571	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247572	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12247573	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12247574	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247575	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247576	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	95.0	CHEMBL4954	Homo sapiens	Residual Activity	%	95.0
	12247577	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	109.0	CHEMBL4954	Homo sapiens	Residual Activity	%	109.0
	12247578	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	115.0	CHEMBL4954	Homo sapiens	Residual Activity	%	115.0
	12247579	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	104.0	CHEMBL4954	Homo sapiens	Residual Activity	%	104.0
	12247580	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12247581	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247582	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247583	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247584	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL4954	Homo sapiens	Residual Activity	%	3.0
	12247585	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL4954	Homo sapiens	Residual Activity	%	104.0
	12247586	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247587	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL4954	Homo sapiens	Residual Activity	%	93.0
	12247588	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247589	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12247590	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247591	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12247592	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12247593	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12247594	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	58.0	CHEMBL4954	Homo sapiens	Residual Activity	%	58.0
	12247595	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12247596	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247597	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	54.0	CHEMBL4954	Homo sapiens	Residual Activity	%	54.0
	12247598	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247599	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247600	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247601	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	117.0	CHEMBL4954	Homo sapiens	Residual Activity	%	117.0
	12247602	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247603	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247604	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247605	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12247606	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	42.0	CHEMBL4954	Homo sapiens	Residual Activity	%	42.0
	12247607	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12247608	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247609	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12247610	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247611	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247612	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL4954	Homo sapiens	Residual Activity	%	89.0
	12247613	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247614	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12247615	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247616	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247617	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	77.0	CHEMBL4954	Homo sapiens	Residual Activity	%	77.0
	12247618	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12247619	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12247620	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	87.0	CHEMBL4954	Homo sapiens	Residual Activity	%	87.0
	12247621	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	80.0	CHEMBL4954	Homo sapiens	Residual Activity	%	80.0
	12247622	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247623	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247624	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL4954	Homo sapiens	Residual Activity	%	104.0
	12247625	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	72.0	CHEMBL4954	Homo sapiens	Residual Activity	%	72.0
	12247626	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	61.0	CHEMBL4954	Homo sapiens	Residual Activity	%	61.0
	12247627	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	82.0	CHEMBL4954	Homo sapiens	Residual Activity	%	82.0
	12247628	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247629	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	41.0	CHEMBL4954	Homo sapiens	Residual Activity	%	41.0
	12247630	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247631	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	86.0	CHEMBL4954	Homo sapiens	Residual Activity	%	86.0
	12247632	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12247633	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	74.0	CHEMBL4954	Homo sapiens	Residual Activity	%	74.0
	12247634	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	65.0	CHEMBL4954	Homo sapiens	Residual Activity	%	65.0
	12247635	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	82.0	CHEMBL4954	Homo sapiens	Residual Activity	%	82.0
	12247636	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	88.0	CHEMBL4954	Homo sapiens	Residual Activity	%	88.0
	12247637	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	75.0	CHEMBL4954	Homo sapiens	Residual Activity	%	75.0
	12247638	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12247639	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	4.0	CHEMBL4954	Homo sapiens	Residual Activity	%	4.0
	12247640	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	93.0	CHEMBL4954	Homo sapiens	Residual Activity	%	93.0
	12247641	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247642	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	88.0	CHEMBL4954	Homo sapiens	Residual Activity	%	88.0
	12247643	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	25.0	CHEMBL4954	Homo sapiens	Residual Activity	%	25.0
	12247644	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	88.0	CHEMBL4954	Homo sapiens	Residual Activity	%	88.0
	12247645	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247646	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247647	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247648	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	58.0	CHEMBL4954	Homo sapiens	Residual Activity	%	58.0
	12247649	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12247650	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247651	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	74.0	CHEMBL4954	Homo sapiens	Residual Activity	%	74.0
	12247652	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247653	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12247654	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247655	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247656	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247657	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247658	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247659	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247660	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	95.0	CHEMBL4954	Homo sapiens	Residual Activity	%	95.0
	12247661	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12247662	CHEMBL2219040	Millipore: Percentage of residual kinase activity of EPHA3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247663	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247664	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12247665	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	114.0	CHEMBL4954	Homo sapiens	Residual Activity	%	114.0
	12247666	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	64.0	CHEMBL4954	Homo sapiens	Residual Activity	%	64.0
	12247667	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	78.0	CHEMBL4954	Homo sapiens	Residual Activity	%	78.0
	12247668	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	84.0	CHEMBL4954	Homo sapiens	Residual Activity	%	84.0
	12247669	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	13.0	CHEMBL4954	Homo sapiens	Residual Activity	%	13.0
	12247670	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	42.0	CHEMBL4954	Homo sapiens	Residual Activity	%	42.0
	12247671	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247672	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	30.0	CHEMBL4954	Homo sapiens	Residual Activity	%	30.0
	12247673	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247674	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	81.0	CHEMBL4954	Homo sapiens	Residual Activity	%	81.0
	12247675	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL4954	Homo sapiens	Residual Activity	%	82.0
	12247676	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	8.0	CHEMBL4954	Homo sapiens	Residual Activity	%	8.0
	12247677	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	36.0	CHEMBL4954	Homo sapiens	Residual Activity	%	36.0
	12247678	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247679	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247680	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247681	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL4954	Homo sapiens	Residual Activity	%	89.0
	12247682	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	72.0	CHEMBL4954	Homo sapiens	Residual Activity	%	72.0
	12247683	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12247684	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	76.0	CHEMBL4954	Homo sapiens	Residual Activity	%	76.0
	12247685	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	95.0	CHEMBL4954	Homo sapiens	Residual Activity	%	95.0
	12247686	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	103.0	CHEMBL4954	Homo sapiens	Residual Activity	%	103.0
	12247687	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247688	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	22.0	CHEMBL4954	Homo sapiens	Residual Activity	%	22.0
	12247689	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	33.0	CHEMBL4954	Homo sapiens	Residual Activity	%	33.0
	12247690	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	20.0	CHEMBL4954	Homo sapiens	Residual Activity	%	20.0
	12247691	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	112.0	CHEMBL4954	Homo sapiens	Residual Activity	%	112.0
	12247692	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	76.0	CHEMBL4954	Homo sapiens	Residual Activity	%	76.0
	12247693	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	78.0	CHEMBL4954	Homo sapiens	Residual Activity	%	78.0
	12247694	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	0.0	CHEMBL4954	Homo sapiens	Residual Activity	%	0.0
	12247695	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	76.0	CHEMBL4954	Homo sapiens	Residual Activity	%	76.0
	12247696	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247697	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	78.0	CHEMBL4954	Homo sapiens	Residual Activity	%	78.0
	12247698	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12247699	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	42.0	CHEMBL4954	Homo sapiens	Residual Activity	%	42.0
	12247700	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	129.0	CHEMBL4954	Homo sapiens	Residual Activity	%	129.0
	12247701	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247702	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247703	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247704	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247705	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	50.0	CHEMBL4954	Homo sapiens	Residual Activity	%	50.0
	12247706	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	75.0	CHEMBL4954	Homo sapiens	Residual Activity	%	75.0
	12247707	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	67.0	CHEMBL4954	Homo sapiens	Residual Activity	%	67.0
	12247708	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247709	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	95.0	CHEMBL4954	Homo sapiens	Residual Activity	%	95.0
	12247710	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	80.0	CHEMBL4954	Homo sapiens	Residual Activity	%	80.0
	12247711	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247712	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	71.0	CHEMBL4954	Homo sapiens	Residual Activity	%	71.0
	12247713	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	60.0	CHEMBL4954	Homo sapiens	Residual Activity	%	60.0
	12247714	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	48.0	CHEMBL4954	Homo sapiens	Residual Activity	%	48.0
	12247715	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	28.0	CHEMBL4954	Homo sapiens	Residual Activity	%	28.0
	12247716	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	50.0	CHEMBL4954	Homo sapiens	Residual Activity	%	50.0
	12247717	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	86.0	CHEMBL4954	Homo sapiens	Residual Activity	%	86.0
	12247718	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	87.0	CHEMBL4954	Homo sapiens	Residual Activity	%	87.0
	12247719	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247720	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	96.0	CHEMBL4954	Homo sapiens	Residual Activity	%	96.0
	12247721	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247722	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	77.0	CHEMBL4954	Homo sapiens	Residual Activity	%	77.0
	12247723	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	54.0	CHEMBL4954	Homo sapiens	Residual Activity	%	54.0
	12247724	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12247725	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247726	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12247727	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	125.0	CHEMBL4954	Homo sapiens	Residual Activity	%	125.0
	12247728	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	100.0	CHEMBL4954	Homo sapiens	Residual Activity	%	100.0
	12247729	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12247730	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	77.0	CHEMBL4954	Homo sapiens	Residual Activity	%	77.0
	12247731	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	87.0	CHEMBL4954	Homo sapiens	Residual Activity	%	87.0
	12247732	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL4954	Homo sapiens	Residual Activity	%	106.0
	12247733	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247734	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	47.0	CHEMBL4954	Homo sapiens	Residual Activity	%	47.0
	12247735	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	82.0	CHEMBL4954	Homo sapiens	Residual Activity	%	82.0
	12247736	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	113.0	CHEMBL4954	Homo sapiens	Residual Activity	%	113.0
	12247737	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	69.0	CHEMBL4954	Homo sapiens	Residual Activity	%	69.0
	12247738	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	69.0	CHEMBL4954	Homo sapiens	Residual Activity	%	69.0
	12247739	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	93.0	CHEMBL4954	Homo sapiens	Residual Activity	%	93.0
	12247740	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	47.0	CHEMBL4954	Homo sapiens	Residual Activity	%	47.0
	12247741	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12247742	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4954	Homo sapiens	Residual Activity	%	0.0
	12247743	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	110.0	CHEMBL4954	Homo sapiens	Residual Activity	%	110.0
	12247744	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	72.0	CHEMBL4954	Homo sapiens	Residual Activity	%	72.0
	12247745	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	86.0	CHEMBL4954	Homo sapiens	Residual Activity	%	86.0
	12247746	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247747	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	77.0	CHEMBL4954	Homo sapiens	Residual Activity	%	77.0
	12247748	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	111.0	CHEMBL4954	Homo sapiens	Residual Activity	%	111.0
	12247749	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247750	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	86.0	CHEMBL4954	Homo sapiens	Residual Activity	%	86.0
	12247751	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12247752	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	9.0	CHEMBL4954	Homo sapiens	Residual Activity	%	9.0
	12247753	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247754	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL4954	Homo sapiens	Residual Activity	%	93.0
	12247755	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	8.0	CHEMBL4954	Homo sapiens	Residual Activity	%	8.0
	12247756	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247757	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL4954	Homo sapiens	Residual Activity	%	102.0
	12247758	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL4954	Homo sapiens	Residual Activity	%	107.0
	12247759	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	114.0	CHEMBL4954	Homo sapiens	Residual Activity	%	114.0
	12247760	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL4954	Homo sapiens	Residual Activity	%	105.0
	12247761	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	97.0	CHEMBL4954	Homo sapiens	Residual Activity	%	97.0
	12247762	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12247763	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12247764	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	5.0	CHEMBL4954	Homo sapiens	Residual Activity	%	5.0
	12247765	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL4954	Homo sapiens	Residual Activity	%	108.0
	12247766	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12247767	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	87.0	CHEMBL4954	Homo sapiens	Residual Activity	%	87.0
	12247768	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	101.0	CHEMBL4954	Homo sapiens	Residual Activity	%	101.0
	12247769	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL4954	Homo sapiens	Residual Activity	%	89.0
	12247770	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	81.0	CHEMBL4954	Homo sapiens	Residual Activity	%	81.0
	12247771	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	84.0	CHEMBL4954	Homo sapiens	Residual Activity	%	84.0
	12247772	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	58.0	CHEMBL4954	Homo sapiens	Residual Activity	%	58.0
	12247773	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12247774	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	77.0	CHEMBL4954	Homo sapiens	Residual Activity	%	77.0
	12247775	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	43.0	CHEMBL4954	Homo sapiens	Residual Activity	%	43.0
	12247776	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	111.0	CHEMBL4954	Homo sapiens	Residual Activity	%	111.0
	12247777	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	111.0	CHEMBL4954	Homo sapiens	Residual Activity	%	111.0
	12247778	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	86.0	CHEMBL4954	Homo sapiens	Residual Activity	%	86.0
	12247779	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	33.0	CHEMBL4954	Homo sapiens	Residual Activity	%	33.0
	12247780	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12247781	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	59.0	CHEMBL4954	Homo sapiens	Residual Activity	%	59.0
	12247782	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12247783	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	30.0	CHEMBL4954	Homo sapiens	Residual Activity	%	30.0
	12247784	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	9.0	CHEMBL4954	Homo sapiens	Residual Activity	%	9.0
	12247785	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	54.0	CHEMBL4954	Homo sapiens	Residual Activity	%	54.0
	12247786	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL4954	Homo sapiens	Residual Activity	%	83.0
	12247787	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	6.0	CHEMBL4954	Homo sapiens	Residual Activity	%	6.0
	12247788	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12250456	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	31.0	CHEMBL4954	Homo sapiens	Residual Activity	%	31.0
	12250457	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	111.0	CHEMBL4954	Homo sapiens	Residual Activity	%	111.0
	12250458	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	49.0	CHEMBL4954	Homo sapiens	Residual Activity	%	49.0
	12250459	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	23.0	CHEMBL4954	Homo sapiens	Residual Activity	%	23.0
	12250460	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	90.0	CHEMBL4954	Homo sapiens	Residual Activity	%	90.0
	12250461	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12250462	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	48.0	CHEMBL4954	Homo sapiens	Residual Activity	%	48.0
	12250463	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	89.0	CHEMBL4954	Homo sapiens	Residual Activity	%	89.0
	12250464	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4954	Homo sapiens	Residual Activity	%	0.0
	12250465	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	52.0	CHEMBL4954	Homo sapiens	Residual Activity	%	52.0
	12250466	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	98.0	CHEMBL4954	Homo sapiens	Residual Activity	%	98.0
	12250467	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	60.0	CHEMBL4954	Homo sapiens	Residual Activity	%	60.0
	12250468	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	3.0	CHEMBL4954	Homo sapiens	Residual Activity	%	3.0
	12250469	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	73.0	CHEMBL4954	Homo sapiens	Residual Activity	%	73.0
	12250470	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	99.0	CHEMBL4954	Homo sapiens	Residual Activity	%	99.0
	12250471	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12250472	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	91.0	CHEMBL4954	Homo sapiens	Residual Activity	%	91.0
	12250473	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	7.0	CHEMBL4954	Homo sapiens	Residual Activity	%	7.0
	12250474	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12250475	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	85.0	CHEMBL4954	Homo sapiens	Residual Activity	%	85.0
	12250476	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	38.0	CHEMBL4954	Homo sapiens	Residual Activity	%	38.0
	12250477	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	66.0	CHEMBL4954	Homo sapiens	Residual Activity	%	66.0
	12250478	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	42.0	CHEMBL4954	Homo sapiens	Residual Activity	%	42.0
	12250479	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	94.0	CHEMBL4954	Homo sapiens	Residual Activity	%	94.0
	12250480	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	71.0	CHEMBL4954	Homo sapiens	Residual Activity	%	71.0
	12250481	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	79.0	CHEMBL4954	Homo sapiens	Residual Activity	%	79.0
	12250482	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	79.0	CHEMBL4954	Homo sapiens	Residual Activity	%	79.0
	12250483	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12250484	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL4954	Homo sapiens	Residual Activity	%	88.0
	12250485	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL4954	Homo sapiens	Residual Activity	%	92.0
	12250486	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	81.0	CHEMBL4954	Homo sapiens	Residual Activity	%	81.0
	12250487	CHEMBL2219041	Millipore: Percentage of residual kinase activity of EPHA3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	72.0	CHEMBL4954	Homo sapiens	Residual Activity	%	72.0
	12649143	CHEMBL2329873	Displacement of ephrin-A1-Fc from EphA3 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	2500.0	CHEMBL4954	Homo sapiens	IC50	uM	2.5
	12729987	CHEMBL2353631	Inhibition of EPHA3 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4954	Homo sapiens	Activity	%	99.0
	12730235	CHEMBL2352920	Inhibition of EPHA3 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	103.0	CHEMBL4954	Homo sapiens	Activity	%	103.0
	12730865	CHEMBL2352213	Inhibition of EPHA3 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	97.0	CHEMBL4954	Homo sapiens	Activity	%	97.0
	13375879	CHEMBL2405141	Inhibition of EPHA3 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL4954	Homo sapiens	INH	%	1.0
	13442372	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	13445507	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	93.0	CHEMBL4954	Homo sapiens	INH	%	93.0
	13448562	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	13448698	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	13451493	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	82.0	CHEMBL4954	Homo sapiens	INH	%	82.0
	13454678	CHEMBL2427804	Competitive binding affinity to EPHA3 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	13872160	CHEMBL3101784	Inhibition of human EphA3 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	83.0	CHEMBL4954	Homo sapiens	Activity	%	83.0
	14582485	CHEMBL3242337	Inhibition of human EphA3 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	107.5	CHEMBL4954	Homo sapiens	Activity	%	107.5
	15008623	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809	=	Tm	degrees C	11.2	CHEMBL4954	Homo sapiens	Tm	degrees C	11.2
	15008624	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2ccc(NC(=S)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12		CHEMBL3321823	=	Tm	degrees C	9.9	CHEMBL4954	Homo sapiens	Tm	degrees C	9.9
	15008625	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1ccccc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321800	=	Tm	degrees C	4.1	CHEMBL4954	Homo sapiens	Tm	degrees C	4.1
	15008626	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1cccc(C)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321801	=	Tm	degrees C	2.6	CHEMBL4954	Homo sapiens	Tm	degrees C	2.6
	15008627	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1cccc(Cl)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321802	=	Tm	degrees C	2.6	CHEMBL4954	Homo sapiens	Tm	degrees C	2.6
	15008628	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	COc1ccc(C)c(-n2c(N)c(C(N)=O)c3nc4ccccc4nc32)c1		CHEMBL3321803	=	Tm	degrees C	1.5	CHEMBL4954	Homo sapiens	Tm	degrees C	1.5
	15008629	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1ccc(CO)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321804	=	Tm	degrees C	3.6	CHEMBL4954	Homo sapiens	Tm	degrees C	3.6
	15008630	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2ccccc2Cl)c2nc3ccccc3nc12		CHEMBL3321805	=	Tm	degrees C	3.0	CHEMBL4954	Homo sapiens	Tm	degrees C	3.0
	15008631	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2ccccc2F)c2nc3ccccc3nc12		CHEMBL3321806	=	Tm	degrees C	2.7	CHEMBL4954	Homo sapiens	Tm	degrees C	2.7
	15008632	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(O)c2)c2nc3ccccc3nc12		CHEMBL3321807	=	Tm	degrees C	7.2	CHEMBL4954	Homo sapiens	Tm	degrees C	7.2
	15008633	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1nnc(-c2cccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)c2)[nH]1		CHEMBL3321808	=	Tm	degrees C	0.1	CHEMBL4954	Homo sapiens	Tm	degrees C	0.1
	15008634	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)C3CC3)c2)c2nc3ccccc3nc12		CHEMBL3321810	=	Tm	degrees C	0.3	CHEMBL4954	Homo sapiens	Tm	degrees C	0.3
	15008635	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321811	=	Tm	degrees C	7.6	CHEMBL4954	Homo sapiens	Tm	degrees C	7.6
	15008636	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321812	=	Tm	degrees C	12.3	CHEMBL4954	Homo sapiens	Tm	degrees C	12.3
	15008637	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2F)c2nc3ccccc3nc12		CHEMBL3321813	=	Tm	degrees C	10.9	CHEMBL4954	Homo sapiens	Tm	degrees C	10.9
	15008638	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(-n4c(N)c(C(N)=O)c5nc6ccccc6nc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3321814	=	Tm	degrees C	15.8	CHEMBL4954	Homo sapiens	Tm	degrees C	15.8
	15008639	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(C(=O)NC3CC3)c2)c2nc3ccccc3nc12		CHEMBL3321815	=	Tm	degrees C	0.6	CHEMBL4954	Homo sapiens	Tm	degrees C	0.6
	15008640	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321816	=	Tm	degrees C	9.1	CHEMBL4954	Homo sapiens	Tm	degrees C	9.1
	15008641	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321817	=	Tm	degrees C	14.4	CHEMBL4954	Homo sapiens	Tm	degrees C	14.4
	15008642	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2F)c2nc3ccccc3nc12		CHEMBL3321818	=	Tm	degrees C	13.0	CHEMBL4954	Homo sapiens	Tm	degrees C	13.0
	15008643	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(-n4c(N)c(C(N)=O)c5nc6ccccc6nc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3321819	=	Tm	degrees C	16.2	CHEMBL4954	Homo sapiens	Tm	degrees C	16.2
	15008644	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)NC3CC3)c2)c2nc3ccccc3nc12		CHEMBL3321820	=	Tm	degrees C	0.3	CHEMBL4954	Homo sapiens	Tm	degrees C	0.3
	15008645	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321821	=	Tm	degrees C	0.7	CHEMBL4954	Homo sapiens	Tm	degrees C	0.7
	15008646	CHEMBL3361795	Binding affinity to EphA3 (unknown origin) assessed as thermal shift at 20 uM after 1 hr by differential scanning fluorimetry	B	NC(=O)c1c(N)n(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12		CHEMBL3321822	=	Tm	degrees C	14.3	CHEMBL4954	Homo sapiens	Tm	degrees C	14.3
	15008657	CHEMBL3361797	Binding affinity to EphA3 (unknown origin) by surface plasmon resonance	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809	=	Kd	nM	8.58	CHEMBL4954	Homo sapiens	Kd	10'-9M	8.58
	15008658	CHEMBL3361797	Binding affinity to EphA3 (unknown origin) by surface plasmon resonance	B	NC(=O)c1c(N)n(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12		CHEMBL3321822	=	Kd	nM	39.3	CHEMBL4954	Homo sapiens	Kd	10'-8M	3.93
	15018580	CHEMBL3361894	Inhibition of EPHA3 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.8	CHEMBL4954	Homo sapiens	INH	%	2.8
	15756026	CHEMBL3630359	Inhibition of EPHA3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	57.37	CHEMBL4954	Homo sapiens	INH	%	57.37
	15757033	CHEMBL3630359	Inhibition of EPHA3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	91.49	CHEMBL4954	Homo sapiens	INH	%	91.49
	15758696	CHEMBL3630359	Inhibition of EPHA3 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	17.49	CHEMBL4954	Homo sapiens	INH	%	17.49
306892	16315971	CHEMBL3707650	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	5.1	CHEMBL4954	Homo sapiens	IC50	nM	5.1
Dose-dependent effect	16392490	CHEMBL3738303	Displacement of biotinylated ephrin-A1-Fc from EphA3 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL4954	Homo sapiens	INH		
	16392513	CHEMBL3738303	Displacement of biotinylated ephrin-A1-Fc from EphA3 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	3500.0	CHEMBL4954	Homo sapiens	IC50	uM	3.5
	16425251	CHEMBL3751272	Inhibition of EphA3 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-3.9	CHEMBL4954	Homo sapiens	INH	%	-3.9
	16431813	CHEMBL3749436	Inhibition of human EPHA3 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	16450828	CHEMBL3762684	Inhibition of EPHA3 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	4.2	CHEMBL4954	Homo sapiens	INH	%	4.2
	16495978	CHEMBL3778569	Inhibition of N-terminal His6-tagged recombinant human EPHA3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-10.0	CHEMBL4954	Homo sapiens	Activity	%	-10.0
	16508165	CHEMBL3778569	Inhibition of N-terminal His6-tagged recombinant human EPHA3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	38.0	CHEMBL4954	Homo sapiens	Activity	%	38.0
	16509142	CHEMBL3778569	Inhibition of N-terminal His6-tagged recombinant human EPHA3 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	10.0	CHEMBL4954	Homo sapiens	Activity	%	10.0
	16614459	CHEMBL3816589	Inhibition of human EPHA3 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-2.0	CHEMBL4954	Homo sapiens	INH	%	-2.0
	16837411	CHEMBL3876078	Inhibition of human recombinant His-tagged EPHA3 cytoplasmic domain (569 to 976 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	2094.0	CHEMBL4954	Homo sapiens	IC50	nM	2094.0
	18048963	CHEMBL4011137	Inhibition of recombinant human His-tagged EPHA3 cytoplasmic domain (569 to 976 residues) expressed in baculovirus expression system	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	<	IC50	nM	19952.62	CHEMBL4954	Homo sapiens	pIC50		4.7
	18048964	CHEMBL4011137	Inhibition of recombinant human His-tagged EPHA3 cytoplasmic domain (569 to 976 residues) expressed in baculovirus expression system	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	<	IC50	nM	19952.62	CHEMBL4954	Homo sapiens	pIC50		4.7
	18053080	CHEMBL4011847	Inhibition of EPHA3 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-3.4	CHEMBL4954	Homo sapiens	INH	%	-3.4
	18114379	CHEMBL4025115	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	95.0	CHEMBL4954	Homo sapiens	Activity	%	95.0
	18134325	CHEMBL4029502	Binding affinity to partial length wild-type human EPHA3 (D604 to K889 residues) expressed in bacterial expression system by kinome scan assay	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	>	Kd	nM	3000.0	CHEMBL4954	Homo sapiens	Kd	nM	3000.0
	18134466	CHEMBL4029549	Binding affinity to partial length wild-type human EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as unbound drug level at 300 nM by KINOMEscan assay	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	=	Fu		0.43	CHEMBL4954	Homo sapiens	Fu	%	43.0
Active	18149662	CHEMBL4033348	Inhibition of human EPHA3 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL4954	Homo sapiens	INH		
Active	18149663	CHEMBL4033348	Inhibition of human EPHA3 at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL4954	Homo sapiens	INH		
	18203639	CHEMBL4043926	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	18253363	CHEMBL4054965	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	65.0	CHEMBL4954	Homo sapiens	Activity	%	65.0
	18253364	CHEMBL4054965	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	88.0	CHEMBL4954	Homo sapiens	Activity	%	88.0
	18265777	CHEMBL4057227	Inhibition of EPHA3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	5.0	CHEMBL4954	Homo sapiens	INH	%	5.0
	18265975	CHEMBL4057425	Inhibition of EPHA3 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL4954	Homo sapiens	INH	%	0.7
	18282107	CHEMBL4120062	Inhibition of recombinant His-tagged human EphA3 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	10.2	CHEMBL4954	Homo sapiens	INH	%	10.2
	18282426	CHEMBL4120062	Inhibition of recombinant His-tagged human EphA3 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	22.9	CHEMBL4954	Homo sapiens	INH	%	22.9
	18282748	CHEMBL4120333	Inhibition of EPHA3 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	5.0	CHEMBL4954	Homo sapiens	INH	%	5.0
	18282975	CHEMBL4120560	Inhibition of EPHA3 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.3	CHEMBL4954	Homo sapiens	INH	%	1.3
	18283199	CHEMBL4120784	Inhibition of EPHA3 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-6.7	CHEMBL4954	Homo sapiens	INH	%	-6.7
	18379910	CHEMBL4145812	Inhibition of EPHA3 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	1.65	CHEMBL4954	Homo sapiens	INH	%	1.65
	18379962	CHEMBL4145863	Inhibition of EPHA3 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	19.72	CHEMBL4954	Homo sapiens	IC50	nM	19.72
	18423281	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccnc2)cc(C(F)(F)F)c1		CHEMBL4170062	=	Inhibition	%	4.2	CHEMBL4954	Homo sapiens	INH	%	4.2
	18423282	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccnc(F)c2)cc(C(F)(F)F)c1		CHEMBL4171519	=	Inhibition	%	9.1	CHEMBL4954	Homo sapiens	INH	%	9.1
	18423283	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=Cc1ccc(-c2cc(C(F)(F)F)cc(S(=O)(=O)NCCc3cccc(F)c3)c2)s1		CHEMBL4166224	=	Inhibition	%	7.8	CHEMBL4954	Homo sapiens	INH	%	7.8
	18423284	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(COc3cccc(C(F)(F)F)c3)cc2)cc(C(F)(F)F)c1		CHEMBL4162777	=	Inhibition	%	28.5	CHEMBL4954	Homo sapiens	INH	%	28.5
	18423285	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	COCCc1ccc(OCc2ccc(-c3cc(C(F)(F)F)cc(S(=O)(=O)NCCc4cccc(F)c4)c3)cc2)cc1		CHEMBL4162362	=	Inhibition	%	33.1	CHEMBL4954	Homo sapiens	INH	%	33.1
	18423286	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccc3c2Sc2ccccc2S3)cc(C(F)(F)F)c1		CHEMBL4173044	=	Inhibition	%	32.8	CHEMBL4954	Homo sapiens	INH	%	32.8
	18423287	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(COc3cccc4ccccc34)cc2)cc(C(F)(F)F)c1		CHEMBL4177505	=	Inhibition	%	30.1	CHEMBL4954	Homo sapiens	INH	%	30.1
	18423288	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccc3c2oc2ccccc23)cc(C(F)(F)F)c1		CHEMBL4169644	=	Inhibition	%	11.1	CHEMBL4954	Homo sapiens	INH	%	11.1
	18423289	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccccc2COc2cccc(C(F)(F)F)c2)cc(C(F)(F)F)c1		CHEMBL4169245	=	Inhibition	%	30.4	CHEMBL4954	Homo sapiens	INH	%	30.4
	18423290	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(-c3cccs3)s2)cc(C(F)(F)F)c1		CHEMBL4161318	=	Inhibition	%	22.0	CHEMBL4954	Homo sapiens	INH	%	22.0
	18423308	CHEMBL4154425	Inhibition of recombinant human N-terminal GST-His6-fused ephA3 expressed in Sf9 insect cells at 10 uM using poly (Glu, Tyr) 4:1 as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cc3ccccc3[nH]2)cc(C(F)(F)F)c1		CHEMBL4173450	=	Inhibition	%	22.7	CHEMBL4954	Homo sapiens	INH	%	22.7
	18440181	CHEMBL4157005	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	18450304	CHEMBL4178320	Inhibition of recombinant human N-terminal GST-tagged EPHA3 (571 to end residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-2.0	CHEMBL4954	Homo sapiens	Activity	%	-2.0
	18450354	CHEMBL4178320	Inhibition of recombinant human N-terminal GST-tagged EPHA3 (571 to end residues) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-3.0	CHEMBL4954	Homo sapiens	Activity	%	-3.0
	18484621	CHEMBL4185784	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	99.0	CHEMBL4954	Homo sapiens	Activity	%	99.0
	18485000	CHEMBL4185784	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	18507806	CHEMBL4190956	Inhibition of recombinant human EPHA3 (578 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	7.0	CHEMBL4954	Homo sapiens	INH	%	7.0
	18653663	CHEMBL4230072	Inhibition of EPH-A3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	98.0	CHEMBL4954	Homo sapiens	INH	%	98.0
	18653664	CHEMBL4230072	Inhibition of EPH-A3 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	76.0	CHEMBL4954	Homo sapiens	INH	%	76.0
	18655551	CHEMBL4230684	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	89.0	CHEMBL4954	Homo sapiens	Activity	%	89.0
	18751124	CHEMBL4263790	Inhibition of EPH-A3 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4954	Homo sapiens	INH	%	3.0
	18751630	CHEMBL4264273	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	94.0	CHEMBL4954	Homo sapiens	Activity	%	94.0
	18857942	CHEMBL4307788	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	18892866	CHEMBL4314832	Inhibition of recombinant human EphA3 (578 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.0	CHEMBL4954	Homo sapiens	Activity	%	102.0
	18919363	CHEMBL4322737	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHA3 (unknown origin) (579 to 983 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	747.0	CHEMBL4954	Homo sapiens	Kd	nM	747.0
Not Determined	18919377	CHEMBL4322737	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHA3 (unknown origin) (579 to 983 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL4954	Homo sapiens	Kd		
	18937887	CHEMBL4327674	Inhibition of human EPHA3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.99	CHEMBL4954	Homo sapiens	Activity	%	100.99
	18937888	CHEMBL4327674	Inhibition of human EPHA3 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	103.79	CHEMBL4954	Homo sapiens	Activity	%	103.79
	18938514	CHEMBL4328034	Inhibition of human EPHA3 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4954	Homo sapiens	Activity	%	65.0
	18938892	CHEMBL4328398	Inhibition of human EPHA3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	31.9	CHEMBL4954	Homo sapiens	IC50	10'-8M	3.19
	18958859	CHEMBL4333378	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	72.0	CHEMBL4954	Homo sapiens	Activity	%	72.0
	18964261	CHEMBL4335068	Inhibition of recombinant human EphA3 (578 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	111.0	CHEMBL4954	Homo sapiens	Activity	%	111.0
	18964262	CHEMBL4335068	Inhibition of recombinant human EphA3 (578 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	97.0	CHEMBL4954	Homo sapiens	Activity	%	97.0
	18971885	CHEMBL4336895	Inhibition of recombinant human EphA3 (578 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	80.0	CHEMBL4954	Homo sapiens	Activity	%	80.0
Not Active	19039796	CHEMBL4351846	Inhibition of recombinant human EphA3 (578 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4954	Homo sapiens	INH		
Active	19041092	CHEMBL4352353	Inhibition of human EPHA3 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4954	Homo sapiens	INH		
	19059561	CHEMBL4357862	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	68.0	CHEMBL4954	Homo sapiens	Activity	%	68.0
	19090132	CHEMBL4365706	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	19091907	CHEMBL4366381	Inhibition of human EPHA3 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	20.62	CHEMBL4954	Homo sapiens	INH	%	20.62
	19092268	CHEMBL4366688	Inhibition of EphA3 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	38.0	CHEMBL4954	Homo sapiens	INH	%	38.0
	19144784	CHEMBL4377800	Inhibition of recombinant human EphA3 (568 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	5.0	CHEMBL4954	Homo sapiens	INH	%	5.0
	19147836	CHEMBL4379310	Inhibition of recombinant human EphA3 (578 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4954	Homo sapiens	IC50	uM	10.0
	19159389	CHEMBL4382493	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	77.0	CHEMBL4954	Homo sapiens	Activity	%	77.0
	19181022	CHEMBL4387233	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA3 (569 to 976 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	2.1	CHEMBL4954	Homo sapiens	INH	%	2.1
	19181248	CHEMBL4387233	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA3 (569 to 976 residues) expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	6.5	CHEMBL4954	Homo sapiens	INH	%	6.5
	19191618	CHEMBL4389212	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	74.0	CHEMBL4954	Homo sapiens	INH	%	74.0
	19191875	CHEMBL4389689	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4954	Homo sapiens	INH	%	100.0
	19199907	CHEMBL4391315	Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	77.0	CHEMBL4954	Homo sapiens	Activity	%	77.0
	19225460	CHEMBL4395880	Inhibition of human recombinant EPHA3 at 1 uM using Ulight-TK peptide as substrate measured after 60 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	76.63	CHEMBL4954	Homo sapiens	INH	%	76.63
	19266403	CHEMBL4405353	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4954	Homo sapiens	INH	%	50.0
	19275983	CHEMBL4407986	Inhibition of recombinant human EPhA3 (578 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	23.0	CHEMBL4954	Homo sapiens	INH	%	23.0
	19476568	CHEMBL4479716	Inhibition of recombinant human His-tagged cytoplasmic EPHA3 expressed in baculovirus expression system by LanthaScreen assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	180.0	CHEMBL4954	Homo sapiens	IC50	nM	180.0
	19476668	CHEMBL4479716	Inhibition of recombinant human His-tagged cytoplasmic EPHA3 expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	52.0	CHEMBL4954	Homo sapiens	IC50	nM	52.0
	19476768	CHEMBL4479716	Inhibition of recombinant human His-tagged cytoplasmic EPHA3 expressed in baculovirus expression system by LanthaScreen assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	22.0	CHEMBL4954	Homo sapiens	IC50	nM	22.0
	19476868	CHEMBL4479716	Inhibition of recombinant human His-tagged cytoplasmic EPHA3 expressed in baculovirus expression system by LanthaScreen assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	>	IC50	nM	100000.0	CHEMBL4954	Homo sapiens	IC50	nM	100000.0
	20598187	CHEMBL4602916	Inhibition of human EPHA3	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL4954	Homo sapiens	IC50	uM	1.0
	20600517	CHEMBL4603469	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA3 (569 to 976 residues) expressed in baculovirus expression system measured after 60 mins in presence of ATP by Lanthascreen assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4954	Homo sapiens	IC50	uM	100.0
	22391980	CHEMBL4667097	Inhibition of tracer 236 binding to recombinant human His-tagged EPHA3 (569 to 976 residues) expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	5.5	CHEMBL4954	Homo sapiens	INH	%	5.5
	22423655	CHEMBL4674403	Inhibition of human EPHA3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	85.64	CHEMBL4954	Homo sapiens	Activity	%	85.64
	22423656	CHEMBL4674403	Inhibition of human EPHA3 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	95.15	CHEMBL4954	Homo sapiens	Activity	%	95.15
	22751923	CHEMBL4700038	Binding affinity to EPHA3 (unknown origin) assessed as increase in change in melting temperature by differential scanning fluorimetric analysis	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)cc1		CHEMBL4792853	=	Delta Tm	degrees C	17.3	CHEMBL4954	Homo sapiens	deltaTm	degrees C	17.3
	22751924	CHEMBL4700038	Binding affinity to EPHA3 (unknown origin) assessed as increase in change in melting temperature by differential scanning fluorimetric analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)n(-c2ccc3ncccc3c2)n1		CHEMBL4784484	=	Delta Tm	degrees C	19.3	CHEMBL4954	Homo sapiens	deltaTm	degrees C	19.3
	22843766	CHEMBL4720752	Inhibition of human EPHA3 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	39.0	CHEMBL4954	Homo sapiens	IC50	10^-8M	3.9
	22844118	CHEMBL4721104	Inhibition of human EPHA3 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	89.66	CHEMBL4954	Homo sapiens	Activity	%	89.66
	22844691	CHEMBL4721366	Inhibition of wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.62	CHEMBL4954	Homo sapiens	Activity	%	99.62
	22883464	CHEMBL4727552	Inhibition of EPHA3 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1		CHEMBL3952214	<	IC50	nM	19952.62	CHEMBL4954	Homo sapiens	pIC50		4.7
	22883465	CHEMBL4727552	Inhibition of EPHA3 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1		CHEMBL4759397	<	IC50	nM	19952.62	CHEMBL4954	Homo sapiens	pIC50		4.7
	22952824	CHEMBL4766761	Inhibition of recombinant human EphA3 (578 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	4.0	CHEMBL4954	Homo sapiens	Activity	%	4.0
	22953088	CHEMBL4767025	Inhibition of recombinant human EphA3 (578 to end residues) using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	552.0	CHEMBL4954	Homo sapiens	IC50	uM	0.552
	23122547	CHEMBL4804898	Inhibition of human EPHA3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	23123242	CHEMBL4805486	Inhibition of human EPHA3 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	93.0	CHEMBL4954	Homo sapiens	Activity	%	93.0
	23123649	CHEMBL4805893	Inhibition of DNA-tagged human EPHA3 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	91.0	CHEMBL4954	Homo sapiens	Activity	%	91.0
	23124574	CHEMBL4806503	Inhibition of human EPHA3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4954	Homo sapiens	Activity	%	100.0
	23124575	CHEMBL4806503	Inhibition of human EPHA3 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	87.0	CHEMBL4954	Homo sapiens	Activity	%	87.0
	23127405	CHEMBL4807593	Inhibition of EPHA3 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	0.0	CHEMBL4954	Homo sapiens	Activity	%	0.0
	23127406	CHEMBL4807593	Inhibition of EPHA3 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	0.0	CHEMBL4954	Homo sapiens	Activity	%	0.0
	23128050	CHEMBL4807825	Inhibition of EPHA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4954	Homo sapiens	Activity	%	25.0
	23128051	CHEMBL4807825	Inhibition of EPHA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4954	Homo sapiens	Activity	%	25.0
	23128052	CHEMBL4807825	Inhibition of EPHA3 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4954	Homo sapiens	Activity	%	25.0
	23223179	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905	=	Kd	nM	9000.0	CHEMBL4954	Homo sapiens	Kd	nM	9000.0
	23223180	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333	=	Kd	nM	7000.0	CHEMBL4954	Homo sapiens	Kd	nM	7000.0
	23223181	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331	=	Kd	nM	7000.0	CHEMBL4954	Homo sapiens	Kd	nM	7000.0
	23223182	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	=	Kd	nM	4000.0	CHEMBL4954	Homo sapiens	Kd	nM	4000.0
	23223183	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	>	Kd	nM	10000.0	CHEMBL4954	Homo sapiens	Kd	nM	10000.0
	23223184	CHEMBL4825027	Binding affinity to N-terminal His tagged EphA3 LBD (unknown origin) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061	=	Kd	nM	1500.0	CHEMBL4954	Homo sapiens	Kd	nM	1500.0
Not Active	23317382	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23317850	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	99.0	CHEMBL4954	Homo sapiens	% Control	%	99.0
Not Active	23318519	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	90.0	CHEMBL4954	Homo sapiens	% Control	%	90.0
Not Active	23319000	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23319637	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23320112	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	95.3	CHEMBL4954	Homo sapiens	% Control	%	95.3
Not Active	23320790	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23321258	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23321888	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	86.0	CHEMBL4954	Homo sapiens	% Control	%	86.0
Not Active	23322356	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	99.0	CHEMBL4954	Homo sapiens	% Control	%	99.0
Not Active	23323045	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL4954	Homo sapiens	% Control	%	91.0
Not Active	23323513	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23323996	CHEMBL4880615	EphA3 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-22.0	CHEMBL4954	Homo sapiens	% inhibition	%	-22.0
Not Active	23324367	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23325002	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	88.0	CHEMBL4954	Homo sapiens	% Control	%	88.0
Not Active	23325470	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23326117	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	78.0	CHEMBL4954	Homo sapiens	% Control	%	78.0
Not Active	23326585	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23327285	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23327753	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	67.0	CHEMBL4954	Homo sapiens	% Control	%	67.0
Not Active	23328340	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	90.0	CHEMBL4954	Homo sapiens	% Control	%	90.0
Not Active	23328808	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	98.0	CHEMBL4954	Homo sapiens	% Control	%	98.0
Not Active	23329329	CHEMBL4881036	EphA3(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	86.0	CHEMBL4954	Homo sapiens	% residual kinase activity	%	86.0
Not Active	23329754	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23330222	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	92.0	CHEMBL4954	Homo sapiens	% Control	%	92.0
Not Active	23330978	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23331446	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23332033	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.8	CHEMBL4954	Homo sapiens	% Control	%	89.8
Not Active	23332499	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23333217	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23333671	CHEMBL4881474	EphA3(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	89.0	CHEMBL4954	Homo sapiens	% residual kinase activity	%	89.0
Not Active	23333856	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	87.0	CHEMBL4954	Homo sapiens	% Control	%	87.0
Not Active	23334324	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23335303	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23335771	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	83.0	CHEMBL4954	Homo sapiens	% Control	%	83.0
Not Active	23336398	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23336866	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	93.0	CHEMBL4954	Homo sapiens	% Control	%	93.0
Not Active	23337581	CHEMBL4881952	EPHA3 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	92.0	CHEMBL4954	Homo sapiens	% Ctrl	%	92.0
Not Active	23337947	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23338415	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	89.0	CHEMBL4954	Homo sapiens	% Control	%	89.0
Not Active	23339027	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23339495	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	85.0	CHEMBL4954	Homo sapiens	% Control	%	85.0
Not Active	23340132	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	90.0	CHEMBL4954	Homo sapiens	% Control	%	90.0
Not Active	23340600	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	87.0	CHEMBL4954	Homo sapiens	% Control	%	87.0
Not Active	23341257	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23341725	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23342341	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23342809	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23343439	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23343907	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL4954	Homo sapiens	% Control	%	89.0
Not Active	23344545	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	99.0	CHEMBL4954	Homo sapiens	% Control	%	99.0
Not Active	23345118	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23345586	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	86.0	CHEMBL4954	Homo sapiens	% Control	%	86.0
Not Active	23346163	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23346632	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	93.7	CHEMBL4954	Homo sapiens	% Control	%	93.7
Not Active	23347240	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	79.4	CHEMBL4954	Homo sapiens	% Control	%	79.4
Not Active	23347723	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23348302	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23348770	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL4954	Homo sapiens	% Control	%	92.0
Not Active	23349357	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23349975	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23350443	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23351048	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23351516	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23352032	CHEMBL4882723	EPHA3 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-3.28	CHEMBL4954	Homo sapiens	% Inhibition	%	-3.2803
Not Active	23352540	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	93.0	CHEMBL4954	Homo sapiens	% Control	%	93.0
Not Active	23353008	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	68.0	CHEMBL4954	Homo sapiens	% Control	%	68.0
Not Active	23353890	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23354358	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23355090	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	96.0	CHEMBL4954	Homo sapiens	% Control	%	96.0
Not Active	23355558	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23356194	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23356662	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23357271	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	85.0	CHEMBL4954	Homo sapiens	% Control	%	85.0
Not Active	23357918	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23358386	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23358972	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	91.3	CHEMBL4954	Homo sapiens	% Control	%	91.3
Not Active	23359570	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23360038	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	92.0	CHEMBL4954	Homo sapiens	% Control	%	92.0
Not Active	23360623	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL4954	Homo sapiens	% Control	%	94.0
Not Active	23361091	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	78.0	CHEMBL4954	Homo sapiens	% Control	%	78.0
Not Active	23361664	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	94.0	CHEMBL4954	Homo sapiens	% Control	%	94.0
Not Active	23362200	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4954	Homo sapiens	% Control	%	94.0
Not Active	23362668	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	88.0	CHEMBL4954	Homo sapiens	% Control	%	88.0
Not Active	23364310	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	90.0	CHEMBL4954	Homo sapiens	% Control	%	90.0
Not Active	23364778	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23365517	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	91.0	CHEMBL4954	Homo sapiens	% Control	%	91.0
Not Active	23366060	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	95.0	CHEMBL4954	Homo sapiens	% Control	%	95.0
Not Active	23366650	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23367118	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	91.0	CHEMBL4954	Homo sapiens	% Control	%	91.0
Not Active	23367554	CHEMBL4883907	EPHA3 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	107.0	CHEMBL4954	Homo sapiens	% Residual activity with Skepinone-L	%	107.0
Not Active	23367996	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	82.0	CHEMBL4954	Homo sapiens	% Control	%	82.0
Not Active	23368464	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL4954	Homo sapiens	% Control	%	91.0
Not Active	23369063	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23369531	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	63.0	CHEMBL4954	Homo sapiens	% Control	%	63.0
Not Active	23370051	CHEMBL4884295	EphA3(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	112.0	CHEMBL4954	Homo sapiens	% residual kinase activity	%	112.0
Not Active	23370499	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23370967	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL4954	Homo sapiens	% Control	%	99.0
Not Active	23371776	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23372244	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	75.0	CHEMBL4954	Homo sapiens	% Control	%	75.0
	23372731	CHEMBL4884696	EphA3(EPA3LGD5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4954	Homo sapiens	pIC50		6.0
	23373140	CHEMBL4884987	EphA3(EPA3LGD5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4954	Homo sapiens	pIC50		6.0
	23373501	CHEMBL4885278	EphA3(EPA3LGD5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4954	Homo sapiens	pIC50		6.0
Not Active	23374969	CHEMBL4885963	EphA3 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	4.5	CHEMBL4954	Homo sapiens	% Inhibition	%	4.5
Not Active	23375236	CHEMBL4886218	EPH receptor A3 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	4.0	CHEMBL4954	Homo sapiens	% inhibition	%	4.0
Not Active	23375671	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	83.0	CHEMBL4954	Homo sapiens	% Control	%	83.0
Not Active	23376139	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	86.0	CHEMBL4954	Homo sapiens	% Control	%	86.0
Not Active	23376716	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	87.0	CHEMBL4954	Homo sapiens	% Control	%	87.0
Not Active	23377185	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23378044	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23378512	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23379679	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	75.0	CHEMBL4954	Homo sapiens	% Control	%	75.0
Not Active	23380147	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4954	Homo sapiens	% Control	%	100.0
Not Active	23380841	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	92.0	CHEMBL4954	Homo sapiens	% Control	%	92.0
Not Active	23381489	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	88.0	CHEMBL4954	Homo sapiens	% Control	%	88.0
Not Active	23381957	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	83.0	CHEMBL4954	Homo sapiens	% Control	%	83.0
Not Active	23382581	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	82.0	CHEMBL4954	Homo sapiens	% Control	%	82.0
Not Active	23383049	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	72.0	CHEMBL4954	Homo sapiens	% Control	%	72.0
Not Active	23383775	CHEMBL4887414	EPHA3 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	85.0	CHEMBL4954	Homo sapiens	% Ctrl	%	85.0
Not Active	23384260	CHEMBL4887855	EphA3(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	4.71	CHEMBL4954	Homo sapiens	% inhibition	%	4.71
Not Active	23384964	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	97.0	CHEMBL4954	Homo sapiens	% Control	%	97.0
Not Active	23385431	CHEMBL4879688	KinomeScan assay: inhibition of EPHA3	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	90.0	CHEMBL4954	Homo sapiens	% Control	%	90.0
